| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | ARHGAP42 RALGAPA1 ELMOD2 IQGAP2 MYO9B RAPGEF5 MCF2L2 RCBTB2 ANKRD27 ASAP1 SH3BP4 VAV3 HERC1 ARHGAP8 ARAP1 DOCK2 DOCK3 HTR2B KALRN RALGPS2 RGS3 TBC1D17 KRIT1 ARHGAP5 ITSN2 | 9.40e-08 | 507 | 287 | 25 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | ARHGAP42 RALGAPA1 ELMOD2 IQGAP2 MYO9B RAPGEF5 MCF2L2 RCBTB2 ANKRD27 ASAP1 SH3BP4 VAV3 HERC1 ARHGAP8 ARAP1 DOCK2 DOCK3 HTR2B KALRN RALGPS2 RGS3 TBC1D17 KRIT1 ARHGAP5 ITSN2 | 9.40e-08 | 507 | 287 | 25 | GO:0030695 |
| GeneOntologyMolecularFunction | ribosomal protein S6 kinase activity | 1.41e-06 | 7 | 287 | 4 | GO:0004711 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | PDGFRA RPS6KA1 RPS6KA2 RPS6KA3 STYK1 PFKFB1 MAP3K5 TWF1 MET PIK3C2G MYO3B RPS6KA6 MAP3K15 TAF1 MAP3K7 DYRK3 KALRN PIK3R3 BRSK2 LRRK1 TEX14 ZAP70 N4BP2 PANK4 ATM BRSK1 FYN FGGY | 1.44e-06 | 709 | 287 | 28 | GO:0016773 |
| GeneOntologyMolecularFunction | GTPase activator activity | ARHGAP42 RALGAPA1 ELMOD2 IQGAP2 MYO9B ANKRD27 ASAP1 VAV3 ARHGAP8 ARAP1 DOCK2 DOCK3 HTR2B RGS3 TBC1D17 ARHGAP5 | 3.08e-06 | 279 | 287 | 16 | GO:0005096 |
| GeneOntologyMolecularFunction | glutamate-gated receptor activity | 3.18e-06 | 17 | 287 | 5 | GO:0004970 | |
| GeneOntologyMolecularFunction | kinase activity | PDGFRA RPS6KA1 RPS6KA2 RPS6KA3 STYK1 PFKFB1 MAP3K5 TWF1 MET PIK3C2G MYO3B RPS6KA6 MAP3K15 TAF1 MAP3K7 DYRK3 KALRN PIK3R3 BRSK2 LRRK1 TEX14 ZAP70 N4BP2 PANK4 ATM BRSK1 FYN FGGY | 5.96e-06 | 764 | 287 | 28 | GO:0016301 |
| GeneOntologyMolecularFunction | AMPA glutamate receptor activity | 1.16e-05 | 4 | 287 | 3 | GO:0004971 | |
| GeneOntologyMolecularFunction | helicase activity | ERCC3 DHX38 CHD3 BLM HFM1 ASCC3 EP400 CHD9 CHD8 DHX30 DDX39A | 1.85e-05 | 158 | 287 | 11 | GO:0004386 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 2.01e-05 | 24 | 287 | 5 | GO:0099507 | |
| GeneOntologyMolecularFunction | glutamate receptor activity | 3.69e-05 | 27 | 287 | 5 | GO:0008066 | |
| GeneOntologyMolecularFunction | protein kinase activity | PDGFRA RPS6KA1 RPS6KA2 RPS6KA3 STYK1 MAP3K5 TWF1 MET MYO3B RPS6KA6 MAP3K15 TAF1 MAP3K7 DYRK3 KALRN BRSK2 LRRK1 TEX14 ZAP70 ATM BRSK1 FYN | 6.10e-05 | 600 | 287 | 22 | GO:0004672 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCA3 ERCC3 ATP7A MYO9B VPS4A DHX38 CHD3 CLPX BLM HFM1 ASCC3 DYNC1H1 DNAH10 CHD9 ABCC9 CHD8 DHX30 DDX39A | 7.59e-05 | 441 | 287 | 18 | GO:0016887 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | PDGFRA RPS6KA1 RPS6KA2 RPS6KA3 STYK1 PFKFB1 MAP3K5 TWF1 MET PIK3C2G MYO3B RPS6KA6 MAP3K15 TAF1 MAP3K7 DYRK3 KALRN PIK3R3 BRSK2 LRRK1 TEX14 ZAP70 POLR3B N4BP2 PANK4 ATM BRSK1 FYN FGGY | 9.18e-05 | 938 | 287 | 29 | GO:0016772 |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 9.32e-05 | 127 | 287 | 9 | GO:0008094 | |
| GeneOntologyMolecularFunction | extracellularly glutamate-gated ion channel activity | 9.85e-05 | 7 | 287 | 3 | GO:0005234 | |
| GeneOntologyMolecularFunction | glutamate-gated calcium ion channel activity | 1.56e-04 | 8 | 287 | 3 | GO:0022849 | |
| GeneOntologyMolecularFunction | UDP-glucose:glycoprotein glucosyltransferase activity | 2.06e-04 | 2 | 287 | 2 | GO:0003980 | |
| GeneOntologyMolecularFunction | armadillo repeat domain binding | 2.31e-04 | 9 | 287 | 3 | GO:0070016 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCA3 ERCC3 ATP7A MYO9B VPS4A DHX38 CHD3 CLPX BLM MYO3B HFM1 ASCC3 DYNC1H1 EP400 DNAH10 CHD9 ABCC9 CHD8 DHX30 MYO15A DDX39A | 2.33e-04 | 614 | 287 | 21 | GO:0140657 |
| GeneOntologyMolecularFunction | GTPase binding | ATP7A IQGAP2 MYO9B VPS4A ANKRD27 SH3BP4 XPO6 UNC13B DOCK2 DOCK3 STRN3 TNPO2 GRIA1 RAB11FIP5 ENO1 | 2.40e-04 | 360 | 287 | 15 | GO:0051020 |
| GeneOntologyMolecularFunction | small GTPase binding | ATP7A IQGAP2 MYO9B VPS4A ANKRD27 SH3BP4 XPO6 UNC13B DOCK2 DOCK3 STRN3 TNPO2 GRIA1 RAB11FIP5 | 2.43e-04 | 321 | 287 | 14 | GO:0031267 |
| GeneOntologyMolecularFunction | glucosyltransferase activity | 2.49e-04 | 22 | 287 | 4 | GO:0046527 | |
| GeneOntologyMolecularFunction | DNA helicase activity | 2.62e-04 | 62 | 287 | 6 | GO:0003678 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | RPS6KA1 RPS6KA2 RPS6KA3 MAP3K5 MYO3B RPS6KA6 MAP3K15 TAF1 MAP3K7 DYRK3 KALRN BRSK2 LRRK1 ATM BRSK1 | 2.63e-04 | 363 | 287 | 15 | GO:0106310 |
| GeneOntologyMolecularFunction | enzyme regulator activity | ARHGAP42 RALGAPA1 ELMOD2 IQGAP2 MYO9B RAPGEF5 RPS6KA1 CTSC RPS6KA3 MCF2L2 CD109 RCBTB2 CLPX PTEN ANKRD27 ASAP1 SH3BP4 FGF13 VAV3 C5 HERC1 ARHGAP8 ARAP1 DOCK2 DOCK3 HTR2B KALRN PIK3R3 CAPN3 RALGPS2 RGS3 TBC1D17 KRIT1 CCNA2 ARHGAP5 ITSN2 FYN | 3.14e-04 | 1418 | 287 | 37 | GO:0030234 |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-3-kinase activity | 4.45e-04 | 11 | 287 | 3 | GO:0016303 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | RAPGEF5 MCF2L2 RCBTB2 ANKRD27 VAV3 HERC1 DOCK2 DOCK3 KALRN RALGPS2 ITSN2 | 5.40e-04 | 231 | 287 | 11 | GO:0005085 |
| GeneOntologyMolecularFunction | enzyme activator activity | ARHGAP42 RALGAPA1 ELMOD2 IQGAP2 MYO9B CTSC CLPX PTEN ANKRD27 ASAP1 FGF13 VAV3 ARHGAP8 ARAP1 DOCK2 DOCK3 HTR2B RGS3 TBC1D17 ARHGAP5 FYN | 5.58e-04 | 656 | 287 | 21 | GO:0008047 |
| GeneOntologyMolecularFunction | UDP-glucosyltransferase activity | 7.55e-04 | 13 | 287 | 3 | GO:0035251 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | GTPBP4 ABCA3 ERCC3 ATP7A MYO9B VPS4A DHX38 CHD3 CLPX BLM GNL2 HFM1 ASCC3 DYNC1H1 DNAH10 CHD9 ABCC9 CHD8 RGS3 DHX30 ARHGAP5 RERGL DDX39A | 8.65e-04 | 775 | 287 | 23 | GO:0017111 |
| GeneOntologyMolecularFunction | magnesium ion binding | RPS6KA1 RPS6KA2 RPS6KA3 MAP3K5 RPS6KA6 MAP3K7 DYRK3 BRSK2 BRSK1 ENDOG ENO1 | 9.37e-04 | 247 | 287 | 11 | GO:0000287 |
| GeneOntologyMolecularFunction | phosphatidate phosphatase activity | 9.51e-04 | 14 | 287 | 3 | GO:0008195 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 9.68e-04 | 31 | 287 | 4 | GO:0099604 | |
| GeneOntologyMolecularFunction | acylglycerol O-acyltransferase activity | 1.09e-03 | 32 | 287 | 4 | GO:0016411 | |
| GeneOntologyMolecularFunction | glutamate receptor binding | 1.10e-03 | 81 | 287 | 6 | GO:0035254 | |
| GeneOntologyMolecularFunction | low-affinity IgG receptor activity | 1.21e-03 | 4 | 287 | 2 | GO:0019772 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration | 1.21e-03 | 4 | 287 | 2 | GO:0099583 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 1.35e-03 | 57 | 287 | 5 | GO:1904315 | |
| GeneOntologyMolecularFunction | 3'-5' DNA helicase activity | 1.43e-03 | 16 | 287 | 3 | GO:0043138 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 1.50e-03 | 262 | 287 | 11 | GO:0140097 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 1.70e-03 | 60 | 287 | 5 | GO:0099529 | |
| GeneOntologyMolecularFunction | immunoglobulin binding | 1.71e-03 | 36 | 287 | 4 | GO:0019865 | |
| GeneOntologyMolecularFunction | ribosome binding | 1.76e-03 | 120 | 287 | 7 | GO:0043022 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.90e-03 | 37 | 287 | 4 | GO:0045505 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 1.90e-03 | 37 | 287 | 4 | GO:0140658 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | RPS6KA1 RPS6KA2 RPS6KA3 MAP3K5 MYO3B RPS6KA6 MAP3K15 TAF1 MAP3K7 DYRK3 KALRN BRSK2 LRRK1 ATM BRSK1 | 2.12e-03 | 446 | 287 | 15 | GO:0004674 |
| GeneOntologyMolecularFunction | scaffold protein binding | 2.24e-03 | 93 | 287 | 6 | GO:0097110 | |
| GeneOntologyMolecularFunction | lipid phosphatase activity | 2.40e-03 | 19 | 287 | 3 | GO:0042577 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | GTPBP4 ABCA3 ERCC3 ATP7A MYO9B VPS4A DHX38 CHD3 CLPX BLM GNL2 HFM1 ASCC3 DYNC1H1 DNAH10 CHD9 ABCC9 CHD8 RGS3 DHX30 ARHGAP5 RERGL DDX39A | 2.42e-03 | 839 | 287 | 23 | GO:0016462 |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 2.42e-03 | 65 | 287 | 5 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 2.42e-03 | 65 | 287 | 5 | GO:0022824 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | GTPBP4 ABCA3 ERCC3 ATP7A MYO9B VPS4A DHX38 CHD3 CLPX BLM GNL2 HFM1 ASCC3 DYNC1H1 DNAH10 CHD9 ABCC9 CHD8 RGS3 DHX30 ARHGAP5 RERGL DDX39A | 2.45e-03 | 840 | 287 | 23 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | GTPBP4 ABCA3 ERCC3 ATP7A MYO9B VPS4A DHX38 CHD3 CLPX BLM GNL2 HFM1 ASCC3 DYNC1H1 DNAH10 CHD9 ABCC9 CHD8 RGS3 DHX30 ARHGAP5 RERGL DDX39A | 2.45e-03 | 840 | 287 | 23 | GO:0016818 |
| GeneOntologyMolecularFunction | IgE receptor activity | 2.97e-03 | 6 | 287 | 2 | GO:0019767 | |
| GeneOntologyMolecularFunction | phosphatidylcholine transfer activity | 2.97e-03 | 6 | 287 | 2 | GO:0120019 | |
| GeneOntologyMolecularFunction | histone H2A deubiquitinase activity | 2.97e-03 | 6 | 287 | 2 | GO:0140950 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 3.23e-03 | 100 | 287 | 6 | GO:0030594 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase binding | 3.32e-03 | 43 | 287 | 4 | GO:0043548 | |
| GeneOntologyMolecularFunction | amyloid-beta binding | 3.56e-03 | 102 | 287 | 6 | GO:0001540 | |
| GeneOntologyMolecularFunction | tau-protein kinase activity | 3.70e-03 | 22 | 287 | 3 | GO:0050321 | |
| GeneOntologyBiologicalProcess | ionotropic glutamate receptor signaling pathway | 1.44e-06 | 27 | 282 | 6 | GO:0035235 | |
| GeneOntologyBiologicalProcess | response to nitrogen compound | RNLS UGGT1 TLR7 PFKFB1 PTEN RYR3 STAT5A MAP3K5 BLM LPIN1 PTPN11 TAAR1 TAF1 SMPD3 MAP3K7 KYNU HTR2B SGTA PIK3R3 BRSK2 GRIA1 GRIA2 ABCC9 CAT GRIN2A GRIN2B CCNA2 CAPN10 LPIN3 DNAI1 NAMPT MTHFR LPIN2 UGGT2 SEL1L2 FYN ZC3HAV1 | 1.18e-05 | 1272 | 282 | 37 | GO:1901698 |
| GeneOntologyBiologicalProcess | glutamate receptor signaling pathway | 1.54e-05 | 59 | 282 | 7 | GO:0007215 | |
| GeneOntologyBiologicalProcess | ligand-gated ion channel signaling pathway | 1.61e-05 | 40 | 282 | 6 | GO:1990806 | |
| GeneOntologyBiologicalProcess | acylglycerol metabolic process | 5.91e-05 | 156 | 282 | 10 | GO:0006639 | |
| GeneOntologyBiologicalProcess | triglyceride metabolic process | 6.38e-05 | 127 | 282 | 9 | GO:0006641 | |
| GeneOntologyBiologicalProcess | neutral lipid metabolic process | 6.58e-05 | 158 | 282 | 10 | GO:0006638 | |
| GeneOntologyBiologicalProcess | glycerolipid metabolic process | ABCA3 AGPAT4 MGLL PTEN LPIN1 PTPN11 PIK3C2G GPAT4 HTR2B PIK3R3 CAT DGAT2L6 LPIN3 LPIN2 MTTP ATM TMEM68 | 9.41e-05 | 429 | 282 | 17 | GO:0046486 |
| GeneOntologyBiologicalProcess | cellular response to nitrogen compound | PTEN RYR3 STAT5A MAP3K5 BLM LPIN1 PTPN11 TAAR1 TAF1 MAP3K7 HTR2B PIK3R3 GRIA1 GRIA2 ABCC9 GRIN2A CCNA2 CAPN10 LPIN3 DNAI1 NAMPT LPIN2 FYN ZC3HAV1 | 1.12e-04 | 752 | 282 | 24 | GO:1901699 |
| GeneOntologyBiologicalProcess | peptidyl-serine modification | GGNBP2 RPS6KA1 RPS6KA2 RPS6KA3 PTEN MET MYO3B RPS6KA6 TAF1 POGLUT2 DYRK3 BRSK2 ATM BRSK1 | 1.37e-04 | 319 | 282 | 14 | GO:0018209 |
| GeneOntologyBiologicalProcess | Fc-gamma receptor signaling pathway | 1.81e-04 | 39 | 282 | 5 | GO:0038094 | |
| GeneOntologyBiologicalProcess | peptidyl-amino acid modification | GGNBP2 ATP7A PDGFRA RPS6KA1 RPS6KA2 RPS6KA3 PTEN STAT5A S100A8 MET PTPN11 MYO3B RPS6KA6 TAF1 POGLUT2 PLOD1 DYRK3 CAPN3 BRSK2 LRRK1 ZAP70 P3H4 CEP41 EHMT1 PRMT3 ATM BRSK1 FYN | 1.84e-04 | 976 | 282 | 28 | GO:0018193 |
| GeneOntologyBiologicalProcess | perforin production | 1.86e-04 | 2 | 282 | 2 | GO:0035944 | |
| GeneOntologyBiologicalProcess | UDP-glucosylation | 1.86e-04 | 2 | 282 | 2 | GO:0097359 | |
| GeneOntologyBiologicalProcess | polysaccharide localization | 1.86e-04 | 2 | 282 | 2 | GO:0033037 | |
| GeneOntologyBiologicalProcess | multi-pass transmembrane protein insertion into ER membrane | 2.00e-04 | 9 | 282 | 3 | GO:0160063 | |
| GeneOntologyBiologicalProcess | Fc receptor signaling pathway | 2.00e-04 | 62 | 282 | 6 | GO:0038093 | |
| GeneOntologyBiologicalProcess | neutral lipid biosynthetic process | 2.19e-04 | 63 | 282 | 6 | GO:0046460 | |
| GeneOntologyBiologicalProcess | acylglycerol biosynthetic process | 2.19e-04 | 63 | 282 | 6 | GO:0046463 | |
| GeneOntologyCellularComponent | ER membrane insertion complex | 3.12e-05 | 14 | 287 | 4 | GO:0072379 | |
| MousePheno | abnormal glutamate-mediated receptor currents | 1.99e-07 | 55 | 224 | 9 | MP:0002886 | |
| MousePheno | abnormal AMPA-mediated synaptic currents | 2.79e-06 | 26 | 224 | 6 | MP:0002885 | |
| Domain | Helicase_C | ERCC3 DHX38 CHD3 BLM HFM1 ASCC3 EP400 CHD9 CHD8 DHX30 DDX39A | 7.55e-07 | 107 | 286 | 11 | PF00271 |
| Domain | HELICc | ERCC3 DHX38 CHD3 BLM HFM1 ASCC3 EP400 CHD9 CHD8 DHX30 DDX39A | 7.55e-07 | 107 | 286 | 11 | SM00490 |
| Domain | Ribosomal_S6_kinase_II | 7.88e-07 | 6 | 286 | 4 | IPR016239 | |
| Domain | Helicase_C | ERCC3 DHX38 CHD3 BLM HFM1 ASCC3 EP400 CHD9 CHD8 DHX30 DDX39A | 8.30e-07 | 108 | 286 | 11 | IPR001650 |
| Domain | DEXDc | ERCC3 DHX38 CHD3 BLM HFM1 ASCC3 EP400 CHD9 CHD8 DHX30 DDX39A | 9.10e-07 | 109 | 286 | 11 | SM00487 |
| Domain | HELICASE_CTER | ERCC3 DHX38 CHD3 BLM HFM1 ASCC3 EP400 CHD9 CHD8 DHX30 DDX39A | 9.10e-07 | 109 | 286 | 11 | PS51194 |
| Domain | HELICASE_ATP_BIND_1 | ERCC3 DHX38 CHD3 BLM HFM1 ASCC3 EP400 CHD9 CHD8 DHX30 DDX39A | 9.10e-07 | 109 | 286 | 11 | PS51192 |
| Domain | Helicase_ATP-bd | ERCC3 DHX38 CHD3 BLM HFM1 ASCC3 EP400 CHD9 CHD8 DHX30 DDX39A | 9.98e-07 | 110 | 286 | 11 | IPR014001 |
| Domain | Lipin_N | 3.55e-06 | 3 | 286 | 3 | IPR007651 | |
| Domain | Lipin_mid | 3.55e-06 | 3 | 286 | 3 | IPR031703 | |
| Domain | Lipin_N | 3.55e-06 | 3 | 286 | 3 | PF04571 | |
| Domain | Lipin_mid | 3.55e-06 | 3 | 286 | 3 | PF16876 | |
| Domain | Glu/Gly-bd | 5.92e-06 | 18 | 286 | 5 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 5.92e-06 | 18 | 286 | 5 | SM00918 | |
| Domain | Iontro_rcpt | 5.92e-06 | 18 | 286 | 5 | IPR001320 | |
| Domain | PBPe | 5.92e-06 | 18 | 286 | 5 | SM00079 | |
| Domain | Lig_chan-Glu_bd | 5.92e-06 | 18 | 286 | 5 | PF10613 | |
| Domain | Iono_rcpt_met | 5.92e-06 | 18 | 286 | 5 | IPR001508 | |
| Domain | Lig_chan | 5.92e-06 | 18 | 286 | 5 | PF00060 | |
| Domain | Kinase-like_dom | PDGFRA RPS6KA1 RPS6KA2 RPS6KA3 STYK1 MAP3K5 MET PIK3C2G MYO3B RPS6KA6 MAP3K15 MAP3K7 DYRK3 KALRN BRSK2 CHD9 ACAD10 LRRK1 TEX14 ZAP70 ATM BRSK1 FYN | 1.12e-05 | 542 | 286 | 23 | IPR011009 |
| Domain | DNA/RNA_helicase_DEAH_CS | 1.37e-05 | 35 | 286 | 6 | IPR002464 | |
| Domain | DUF2012 | 1.41e-05 | 4 | 286 | 3 | PF09430 | |
| Domain | DUF2012 | 1.41e-05 | 4 | 286 | 3 | IPR019008 | |
| Domain | - | FEM1C CFAP54 CLUH ZMYND12 SGTA P3H4 TTC23 VPS41 TTC21B TTC39A IFT122 SEL1L2 CFAP46 | 1.93e-05 | 207 | 286 | 13 | 1.25.40.10 |
| Domain | DEAH_ATP_HELICASE | 2.24e-05 | 38 | 286 | 6 | PS00690 | |
| Domain | CarboxyPept_regulatory_dom | 3.45e-05 | 13 | 286 | 4 | IPR014766 | |
| Domain | - | 3.45e-05 | 13 | 286 | 4 | 2.60.40.1120 | |
| Domain | TPR-like_helical_dom | FEM1C CFAP54 CLUH ZMYND12 SGTA P3H4 TTC23 VPS41 TTC21B TTC39A IFT122 SEL1L2 CFAP46 | 6.58e-05 | 233 | 286 | 13 | IPR011990 |
| Domain | LNS2 | 6.87e-05 | 6 | 286 | 3 | PF08235 | |
| Domain | LNS2 | 6.87e-05 | 6 | 286 | 3 | IPR013209 | |
| Domain | LNS2 | 6.87e-05 | 6 | 286 | 3 | SM00775 | |
| Domain | LNS2/PITP | 6.87e-05 | 6 | 286 | 3 | IPR031315 | |
| Domain | CarboxyPept-like_regulatory | 1.09e-04 | 17 | 286 | 4 | IPR008969 | |
| Domain | Carb-bd-like_fold | 1.88e-04 | 8 | 286 | 3 | IPR013784 | |
| Domain | Prot_kinase_dom | PDGFRA RPS6KA1 RPS6KA2 RPS6KA3 STYK1 MAP3K5 MET MYO3B RPS6KA6 MAP3K15 MAP3K7 DYRK3 KALRN BRSK2 LRRK1 TEX14 ZAP70 BRSK1 FYN | 2.06e-04 | 489 | 286 | 19 | IPR000719 |
| Domain | - | GTPBP4 ABCA3 ERCC3 VPS4A DHX38 CHD3 PFKFB1 CLPX BLM GNL2 HFM1 ASCC3 DYNC1H1 EP400 DNAH10 CHD9 ABCC9 CHD8 LRRK1 DHX30 ARHGAP5 RERGL N4BP2 MYO15A DDX39A | 2.17e-04 | 746 | 286 | 25 | 3.40.50.300 |
| Domain | PROTEIN_KINASE_DOM | PDGFRA RPS6KA1 RPS6KA2 RPS6KA3 STYK1 MAP3K5 MET MYO3B RPS6KA6 MAP3K15 MAP3K7 DYRK3 KALRN BRSK2 LRRK1 TEX14 ZAP70 BRSK1 FYN | 2.28e-04 | 493 | 286 | 19 | PS50011 |
| Domain | SIM_C | 2.34e-04 | 2 | 286 | 2 | PS51302 | |
| Domain | UDP-g_GGTase | 2.34e-04 | 2 | 286 | 2 | PF06427 | |
| Domain | SIM_C | 2.34e-04 | 2 | 286 | 2 | IPR010578 | |
| Domain | UDP-g_GGtrans | 2.34e-04 | 2 | 286 | 2 | IPR009448 | |
| Domain | SIM_C | 2.34e-04 | 2 | 286 | 2 | PF06621 | |
| Domain | ANF_lig-bd_rcpt | 2.37e-04 | 37 | 286 | 5 | IPR001828 | |
| Domain | ANF_receptor | 2.37e-04 | 37 | 286 | 5 | PF01094 | |
| Domain | Protein_kinase_ATP_BS | PDGFRA RPS6KA1 RPS6KA2 RPS6KA3 MAP3K5 MET MYO3B RPS6KA6 MAP3K15 MAP3K7 DYRK3 KALRN BRSK2 ZAP70 BRSK1 FYN | 2.62e-04 | 379 | 286 | 16 | IPR017441 |
| Domain | PROTEIN_KINASE_ATP | PDGFRA RPS6KA1 RPS6KA2 RPS6KA3 STYK1 MAP3K5 MET MYO3B RPS6KA6 MAP3K15 MAP3K7 DYRK3 KALRN BRSK2 LRRK1 ZAP70 BRSK1 FYN | 2.70e-04 | 459 | 286 | 18 | PS00107 |
| Domain | P-loop_NTPase | GTPBP4 ABCA3 ERCC3 MYO9B VPS4A DHX38 CHD3 PFKFB1 CLPX BLM MYO3B GNL2 HFM1 ASCC3 DYNC1H1 EP400 DNAH10 CHD9 ABCC9 CHD8 LRRK1 DHX30 ARHGAP5 RERGL N4BP2 MYO15A DDX39A | 2.75e-04 | 848 | 286 | 27 | IPR027417 |
| Domain | Peripla_BP_I | 3.06e-04 | 39 | 286 | 5 | IPR028082 | |
| Domain | Rho_GTPase_activation_prot | 4.04e-04 | 88 | 286 | 7 | IPR008936 | |
| Domain | SH3 | ARHGAP42 NEB ASAP1 SH3BP4 VAV3 DOCK2 DOCK3 KALRN ITSN2 MYO15A FYN | 5.19e-04 | 216 | 286 | 11 | PS50002 |
| Domain | SH3 | ARHGAP42 NEB ASAP1 SH3BP4 VAV3 DOCK2 DOCK3 KALRN ITSN2 MYO15A FYN | 5.19e-04 | 216 | 286 | 11 | SM00326 |
| Domain | SH3_domain | ARHGAP42 NEB ASAP1 SH3BP4 VAV3 DOCK2 DOCK3 KALRN ITSN2 MYO15A FYN | 6.04e-04 | 220 | 286 | 11 | IPR001452 |
| Domain | Striatin | 6.94e-04 | 3 | 286 | 2 | PF08232 | |
| Domain | NMDAR2_C | 6.94e-04 | 3 | 286 | 2 | PF10565 | |
| Domain | Striatin_N | 6.94e-04 | 3 | 286 | 2 | IPR013258 | |
| Domain | DUF4071 | 6.94e-04 | 3 | 286 | 2 | PF13281 | |
| Domain | NMDAR2_C | 6.94e-04 | 3 | 286 | 2 | IPR018884 | |
| Domain | DUF4071 | 6.94e-04 | 3 | 286 | 2 | IPR025136 | |
| Domain | DEAD/DEAH_box_helicase_dom | 8.82e-04 | 73 | 286 | 6 | IPR011545 | |
| Domain | DEAD | 8.82e-04 | 73 | 286 | 6 | PF00270 | |
| Domain | TPR | 1.02e-03 | 165 | 286 | 9 | PS50005 | |
| Domain | TPR_REGION | 1.02e-03 | 165 | 286 | 9 | PS50293 | |
| Domain | zf-H2C2_2 | 1.14e-03 | 14 | 286 | 3 | PF13465 | |
| Domain | S_TKc | PDGFRA RPS6KA1 RPS6KA2 RPS6KA3 MAP3K5 MYO3B RPS6KA6 MAP3K15 MAP3K7 DYRK3 KALRN BRSK2 LRRK1 BRSK1 | 1.35e-03 | 359 | 286 | 14 | SM00220 |
| Domain | Sec63 | 1.37e-03 | 4 | 286 | 2 | PF02889 | |
| Domain | Sec63 | 1.37e-03 | 4 | 286 | 2 | SM00973 | |
| Domain | Sec63-dom | 1.37e-03 | 4 | 286 | 2 | IPR004179 | |
| Domain | SNF2_N | 1.38e-03 | 32 | 286 | 4 | PF00176 | |
| Domain | SNF2_N | 1.38e-03 | 32 | 286 | 4 | IPR000330 | |
| Domain | IQ | 1.52e-03 | 81 | 286 | 6 | SM00015 | |
| Domain | - | ANKS6 FEM1C ANKRD27 ASAP1 ANKRD61 TRPC7 LRRK1 TEX14 KRIT1 EHMT1 INVS | 1.60e-03 | 248 | 286 | 11 | 1.25.40.20 |
| Domain | Acyltransferase | 1.72e-03 | 16 | 286 | 3 | PF01553 | |
| Domain | ANK | ANKS6 FEM1C ANKRD27 ASAP1 ANKRD61 TRPC7 LRRK1 TEX14 KRIT1 EHMT1 INVS | 1.76e-03 | 251 | 286 | 11 | SM00248 |
| Domain | Ank_2 | ANKS6 FEM1C ANKRD27 ASAP1 ANKRD61 TRPC7 LRRK1 TEX14 EHMT1 INVS | 1.82e-03 | 215 | 286 | 10 | PF12796 |
| Domain | ANK_REPEAT | ANKS6 FEM1C ANKRD27 ASAP1 ANKRD61 TRPC7 LRRK1 TEX14 KRIT1 EHMT1 INVS | 1.87e-03 | 253 | 286 | 11 | PS50088 |
| Domain | Ankyrin_rpt-contain_dom | ANKS6 FEM1C ANKRD27 ASAP1 ANKRD61 TRPC7 LRRK1 TEX14 KRIT1 EHMT1 INVS | 1.93e-03 | 254 | 286 | 11 | IPR020683 |
| Domain | ANK_REP_REGION | ANKS6 FEM1C ANKRD27 ASAP1 ANKRD61 TRPC7 LRRK1 TEX14 KRIT1 EHMT1 INVS | 1.93e-03 | 254 | 286 | 11 | PS50297 |
| Domain | PlsC | 2.06e-03 | 17 | 286 | 3 | SM00563 | |
| Domain | Plipid/glycerol_acylTrfase | 2.06e-03 | 17 | 286 | 3 | IPR002123 | |
| Domain | SH3_2 | 2.06e-03 | 86 | 286 | 6 | PF07653 | |
| Domain | SH3_2 | 2.06e-03 | 86 | 286 | 6 | IPR011511 | |
| Domain | DOCK_N | 2.27e-03 | 5 | 286 | 2 | PF16172 | |
| Domain | TRAPP_component | 2.27e-03 | 5 | 286 | 2 | IPR007194 | |
| Domain | DOCK_N | 2.27e-03 | 5 | 286 | 2 | IPR032376 | |
| Domain | TRAPP | 2.27e-03 | 5 | 286 | 2 | PF04051 | |
| Domain | Pkinase_C | 2.39e-03 | 37 | 286 | 4 | IPR017892 | |
| Domain | Ankyrin_rpt | ANKS6 FEM1C ANKRD27 ASAP1 ANKRD61 TRPC7 LRRK1 TEX14 KRIT1 EHMT1 INVS | 2.46e-03 | 262 | 286 | 11 | IPR002110 |
| Domain | RhoGAP | 2.58e-03 | 62 | 286 | 5 | SM00324 | |
| Domain | IQ_motif_EF-hand-BS | 2.60e-03 | 90 | 286 | 6 | IPR000048 | |
| Domain | LAM_G_DOMAIN | 2.64e-03 | 38 | 286 | 4 | PS50025 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 3.67e-08 | 35 | 211 | 8 | MM15109 | |
| Pathway | REACTOME_CREB1_PHOSPHORYLATION_THROUGH_NMDA_RECEPTOR_MEDIATED_ACTIVATION_OF_RAS_SIGNALING | 2.41e-07 | 5 | 211 | 4 | MM15108 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ERK_RSK_SIGNALING | 7.15e-07 | 6 | 211 | 4 | M47936 | |
| Pathway | REACTOME_RSK_ACTIVATION | 1.65e-06 | 7 | 211 | 4 | M27369 | |
| Pathway | WP_NRXN1_DELETION_SYNDROME | 5.24e-06 | 18 | 211 | 5 | M48098 | |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 9.39e-06 | 70 | 211 | 8 | M3115 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | RPS6KA1 RPS6KA2 RPS6KA3 RPS6KA6 GRIA1 GRIA2 GRIA4 GRIN2A GRIN2B | 1.13e-05 | 94 | 211 | 9 | M2843 |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 1.20e-05 | 21 | 211 | 5 | M838 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 1.20e-05 | 21 | 211 | 5 | M27736 | |
| Pathway | REACTOME_CREB1_PHOSPHORYLATION_THROUGH_NMDA_RECEPTOR_MEDIATED_ACTIVATION_OF_RAS_SIGNALING | 5.32e-05 | 28 | 211 | 5 | M837 | |
| Pathway | REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS | 5.85e-05 | 15 | 211 | 4 | MM15103 | |
| Pathway | WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING | RPS6KA1 RPS6KA3 STAT5A PTPN11 VAV3 DOCK3 GRIA1 GRIA2 GRIN2B FYN | 6.12e-05 | 144 | 211 | 10 | M39691 |
| Pathway | REACTOME_CELLULAR_SENESCENCE | 7.42e-05 | 119 | 211 | 9 | MM14901 | |
| Pathway | REACTOME_CREB_PHOSPHORYLATION | 1.11e-04 | 7 | 211 | 3 | M27096 | |
| Pathway | REACTOME_CREB_PHOSPHORYLATION | 1.11e-04 | 7 | 211 | 3 | MM14784 | |
| Pathway | REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_FYN | 1.11e-04 | 7 | 211 | 3 | M27912 | |
| Pathway | REACTOME_RHOG_GTPASE_CYCLE | 1.17e-04 | 74 | 211 | 7 | M41814 | |
| Pathway | WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY | 1.27e-04 | 18 | 211 | 4 | M42546 | |
| Pathway | REACTOME_MECP2_REGULATES_NEURONAL_RECEPTORS_AND_CHANNELS | 1.27e-04 | 18 | 211 | 4 | M27901 | |
| Pathway | KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS | 1.34e-04 | 53 | 211 | 6 | M3812 | |
| Pathway | WP_INSULIN_SIGNALING | RPS6KA1 RPS6KA2 RPS6KA3 PTEN MAP3K5 PTPN11 PIK3C2G RPS6KA6 MAP3K7 PIK3R3 | 1.48e-04 | 160 | 211 | 10 | MM15956 |
| Pathway | WP_INSULIN_SIGNALING | RPS6KA1 RPS6KA2 RPS6KA3 PTEN MAP3K5 PTPN11 PIK3C2G RPS6KA6 MAP3K7 PIK3R3 | 1.48e-04 | 160 | 211 | 10 | M39482 |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | ARHGAP42 RALGAPA1 IQGAP2 MYO9B TWF1 VAV3 ARHGAP8 FAM135A ARAP1 DOCK2 DOCK3 KALRN PIK3R3 ZAP70 LETM1 FAM83B ARHGAP5 ITSN2 | 1.48e-04 | 450 | 211 | 18 | M27078 |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 1.96e-04 | 20 | 211 | 4 | MM15485 | |
| Pathway | REACTOME_SENESCENCE_ASSOCIATED_SECRETORY_PHENOTYPE_SASP | 2.73e-04 | 39 | 211 | 5 | MM14900 | |
| Pathway | WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA | 2.89e-04 | 22 | 211 | 4 | M39795 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 2.89e-04 | 22 | 211 | 4 | MM15104 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | ARHGAP42 RALGAPA1 IQGAP2 CENPC MYO9B TWF1 S100A8 SGO2 VAV3 ARHGAP8 FAM135A DYNC1H1 ARAP1 DOCK2 KALRN PIK3R3 PRC1 ZAP70 LETM1 FAM83B ARHGAP5 ITSN2 | 2.95e-04 | 649 | 211 | 22 | MM15690 |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | ARHGAP42 RALGAPA1 IQGAP2 MYO9B TWF1 VAV3 ARHGAP8 FAM135A ARAP1 DOCK2 KALRN PIK3R3 ZAP70 LETM1 FAM83B ARHGAP5 ITSN2 | 3.31e-04 | 439 | 211 | 17 | MM15595 |
| Pathway | REACTOME_LONG_TERM_POTENTIATION | 3.45e-04 | 23 | 211 | 4 | M27949 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | ARHGAP42 IQGAP2 MYO9B VAV3 ARAP1 DOCK2 DOCK3 KALRN PIK3R3 ARHGAP5 | 4.55e-04 | 184 | 211 | 10 | M41809 |
| Pathway | REACTOME_SIGNALING_BY_NTRK2_TRKB | 4.82e-04 | 25 | 211 | 4 | M27864 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | ARHGAP42 RALGAPA1 IQGAP2 CENPC MYO9B TWF1 S100A8 SGO2 VAV3 ARHGAP8 FAM135A DYNC1H1 ARAP1 DOCK2 DOCK3 KALRN PIK3R3 PRC1 ZAP70 LETM1 FAM83B ARHGAP5 ITSN2 | 4.96e-04 | 720 | 211 | 23 | M41838 |
| Pathway | PID_RHOA_REG_PATHWAY | 5.96e-04 | 46 | 211 | 5 | M68 | |
| Pathway | REACTOME_DEPOLYMERIZATION_OF_THE_NUCLEAR_LAMINA | 6.58e-04 | 12 | 211 | 3 | MM15105 | |
| Pathway | REACTOME_SYNTHESIS_OF_PE | 6.58e-04 | 12 | 211 | 3 | MM14586 | |
| Pathway | REACTOME_TRIGLYCERIDE_BIOSYNTHESIS | 6.58e-04 | 12 | 211 | 3 | MM15447 | |
| Pathway | REACTOME_RHOG_GTPASE_CYCLE | 6.68e-04 | 71 | 211 | 6 | MM15604 | |
| Pathway | REACTOME_PHOSPHOLIPID_METABOLISM | AGPAT4 MGLL PTEN LPIN1 PIK3C2G GPAT4 PIK3R3 DGAT2L6 LPIN3 LPIN2 | 7.44e-04 | 196 | 211 | 10 | MM14591 |
| Pathway | WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY | RPS6KA1 RPS6KA2 RPS6KA3 MAP3K5 PIK3C2G RPS6KA6 MAP3K7 PIK3R3 | 8.31e-04 | 132 | 211 | 8 | M39338 |
| Pathway | REACTOME_SYNTHESIS_OF_PE | 8.46e-04 | 13 | 211 | 3 | M656 | |
| Pubmed | RALGAPA1 GTPBP4 ATP7A CENPC UGGT1 SPART RTN3 CLPX SSRP1 PLXNB2 SH3BP4 BLM MET NOMO2 GNL2 ASCC3 PLOD1 FAM135A CLUH GPAT4 SYNE1 SGTA PIK3R3 LETM1 TBC1D17 FAM83B DHX30 NOMO1 N4BP2 PANK4 EHMT1 RAB11FIP5 UGGT2 IFT122 ATM POLDIP2 ENDOG RPL3 ZC3HAV1 | 2.49e-10 | 1487 | 289 | 39 | 33957083 | |
| Pubmed | GGNBP2 IQGAP2 CENPC UGGT1 NMRAL1 CHD3 CLPX SSRP1 NEB NUP205 STRN HSD17B4 DTHD1 BBOF1 STRN3 SYNE1 GRIA1 GRIA2 GRIA4 CAT OGFOD3 TEX14 LETM1 N4BP2 UNC5C ITSN2 MTTP UGGT2 IFT122 EIF3A ATM DDX39A ENO1 RPL3 CFAP46 ZNF292 | 4.75e-09 | 1442 | 289 | 36 | 35575683 | |
| Pubmed | GGNBP2 RPS6KA1 DHX38 CHD3 CLPX ANKRD27 SH3BP4 LPIN1 HSD17B4 KYNU CHD8 CLSTN1 RGS3 LETM1 TBC1D17 LPIN3 TGFBI NAMPT UGGT2 IFT122 POLDIP2 RPL3 ZC3HAV1 | 7.31e-09 | 650 | 289 | 23 | 38777146 | |
| Pubmed | The RSK2-RPS6 axis promotes axonal regeneration in the peripheral and central nervous systems. | 2.32e-08 | 5 | 289 | 4 | 37068088 | |
| Pubmed | Cognitive impairment in Coffin-Lowry syndrome correlates with reduced RSK2 activation. | 2.32e-08 | 5 | 289 | 4 | 11160957 | |
| Pubmed | 2.32e-08 | 5 | 289 | 4 | 24416220 | ||
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | CTSC UGGT1 DHX38 CLPX TWF1 PTPN11 GLA NOMO2 VAV3 DYNC1H1 VPS26B CAT NOMO1 EIF3A ENO1 NOMO3 | 3.85e-08 | 344 | 289 | 16 | 30333137 |
| Pubmed | CNKSR1 CNST MCF2L2 ETS2 NUP58 RYR3 ME3 SATB1 NOMO2 TAF1 SMPD3 HSD17B4 DYNC1H1 UNC13B DOCK3 CNTN4 KALRN TNPO2 SYNE1 SGTA CHD9 GRIN2B SIM2 KRIT1 DHX30 ARHGAP5 POLR3B ZNF92 IFT122 ATM POLDIP2 ZNF292 | 3.88e-08 | 1285 | 289 | 32 | 35914814 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ANKS6 MYO9B RPS6KA2 PLXNB2 MAP3K5 SH3BP4 PLEKHM2 XPO6 HERC1 GPAT4 DYNC1H1 ARAP1 IGSF3 UNC13B DOCK3 EP400 KALRN CHD8 LRRK1 TBC1D17 KCNH3 DHX30 LPIN3 OVOL1 MROH1 MTHFR EHMT1 KCNK5 ENDOG | 5.84e-08 | 1105 | 289 | 29 | 35748872 |
| Pubmed | 6.91e-08 | 6 | 289 | 4 | 12832467 | ||
| Pubmed | 6.91e-08 | 6 | 289 | 4 | 20418887 | ||
| Pubmed | 6.91e-08 | 6 | 289 | 4 | 18922769 | ||
| Pubmed | 1.07e-07 | 15 | 289 | 5 | 9481670 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | GTPBP4 ERCC3 CENPC MYO9B VPS4A DHX38 CLPX SSRP1 ANKRD27 ASAP1 NUP205 BLM S100A8 ASCC3 PLOD1 USP3 DYNC1H1 TCF20 EP400 CAT CHD8 DHX30 NMD3 GTF2H1 POLR3B NAMPT PRMT3 EIF3A DDX39A ENO1 RPL3 ZC3HAV1 | 1.25e-07 | 1353 | 289 | 32 | 29467282 |
| Pubmed | Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3. | 1.60e-07 | 7 | 289 | 4 | 21558424 | |
| Pubmed | Transmembrane topology of the glutamate receptor subunit GluR6. | 3.18e-07 | 8 | 289 | 4 | 8163463 | |
| Pubmed | 3.18e-07 | 8 | 289 | 4 | 14602821 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | B4GALT7 ERAP1 CTSC UGGT1 CD109 CNTNAP3 RTN3 PLXNB2 MET GLA NOMO2 XPO6 POGLUT2 PLOD1 GPAT4 IGSF3 FAT4 ARV1 GXYLT1 MANEA OGFOD3 CLSTN1 P3H4 NOMO1 TGFBI UGGT2 EIF3A ATM OSMR | 3.31e-07 | 1201 | 289 | 29 | 35696571 |
| Pubmed | ATP7A TCEAL4 UGGT1 SPART CLPX SSRP1 ANKRD27 TWF1 GLA NOMO2 POGLUT2 PLOD1 FAM135A GPAT4 RADX SGTA PRC1 CCNA2 YEATS4 ITSN2 CEP41 RAB11FIP5 UGGT2 EIF3A DDX39A ZC3HAV1 | 4.00e-07 | 1007 | 289 | 26 | 34597346 | |
| Pubmed | Temporal and spatial regulation of the phosphatidate phosphatases lipin 1 and 2. | 5.68e-07 | 3 | 289 | 3 | 18694939 | |
| Pubmed | 5.68e-07 | 3 | 289 | 3 | 28608743 | ||
| Pubmed | 5.68e-07 | 3 | 289 | 3 | 12393804 | ||
| Pubmed | Case-control association study of GRIA1, GRIA2 and GRIA4 polymorphisms in bipolar disorder. | 5.68e-07 | 3 | 289 | 3 | 22122651 | |
| Pubmed | 5.68e-07 | 3 | 289 | 3 | 22094384 | ||
| Pubmed | 5.68e-07 | 3 | 289 | 3 | 22057216 | ||
| Pubmed | 5.68e-07 | 3 | 289 | 3 | 20735359 | ||
| Pubmed | Study of LPIN1, LPIN2 and LPIN3 in rhabdomyolysis and exercise-induced myalgia. | 5.68e-07 | 3 | 289 | 3 | 22481384 | |
| Pubmed | Elevated GRIA1 mRNA expression in Layer II/III and V pyramidal cells of the DLPFC in schizophrenia. | 5.68e-07 | 3 | 289 | 3 | 17942280 | |
| Pubmed | Three mammalian lipins act as phosphatidate phosphatases with distinct tissue expression patterns. | 5.68e-07 | 3 | 289 | 3 | 17158099 | |
| Pubmed | 5.68e-07 | 3 | 289 | 3 | 10884287 | ||
| Pubmed | Identification of lipidomic profiles associated with drug-resistant prostate cancer cells. | 5.68e-07 | 3 | 289 | 3 | 33596934 | |
| Pubmed | 5.68e-07 | 3 | 289 | 3 | 36011023 | ||
| Pubmed | 5.68e-07 | 3 | 289 | 3 | 26977024 | ||
| Pubmed | 5.68e-07 | 3 | 289 | 3 | 30507612 | ||
| Pubmed | 5.68e-07 | 3 | 289 | 3 | 24634820 | ||
| Pubmed | Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes. | 5.68e-07 | 3 | 289 | 3 | 25576386 | |
| Pubmed | Human rsk isoforms: cloning and characterization of tissue-specific expression. | 5.68e-07 | 3 | 289 | 3 | 8141249 | |
| Pubmed | PDGFRA RPS6KA2 RPS6KA3 PTEN STAT5A MAP3K5 MET PTPN11 FCGR3A MAP3K7 DOCK2 PIK3R3 GRIN2B OSMR FYN | 6.15e-07 | 371 | 289 | 15 | 25241761 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | GTPBP4 ZNF845 CENPC CHD3 SSRP1 BLM SATB1 GNL2 SGO2 TAF1 USP3 TCF20 RADX CHD9 CHD8 ZFP1 EHMT1 ZHX1 ZNF292 | 9.99e-07 | 608 | 289 | 19 | 36089195 |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | GTPBP4 ERCC3 DHX38 SSRP1 NUP205 BLM GNL2 SGO2 ASCC3 PLOD1 EP400 CHD8 PRC1 DHX30 RPL3 ZC3HAV1 | 1.05e-06 | 440 | 289 | 16 | 34244565 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | GTPBP4 VPS4A UGGT1 DHX38 RTN3 CLPX SSRP1 NUP205 S100A8 PTPN11 GNL2 SGO2 HSD17B4 CLUH DYNC1H1 DNAH10 SYNE1 PRC1 LETM1 DHX30 NOMO1 NMD3 NAMPT EHMT1 PRMT3 EIF3A ATM POLDIP2 ENO1 RPL3 ZC3HAV1 | 1.17e-06 | 1425 | 289 | 31 | 30948266 |
| Pubmed | RALGAPA1 ANKS6 ATP7A RTN3 ANKRD27 SH3BP4 COG6 PLEKHM2 RMC1 FAM135A GPAT4 VPS26B VPS8 FAM83B VPS41 RAB11FIP5 ZC3HAV1 | 1.35e-06 | 504 | 289 | 17 | 34432599 | |
| Pubmed | Glutamate can act as a signaling molecule in mouse preimplantation embryos†. | 1.43e-06 | 24 | 289 | 5 | 35746896 | |
| Pubmed | GTPBP4 ERCC3 CENPC TCEAL4 DHX38 CHD3 SSRP1 NUP205 BLM PTPN11 TAF1 KYNU CDCA7L TCF20 EP400 CHD9 CHD8 PRC1 CCNA2 POLR3B NAMPT EHMT1 EIF3A ATM MYO15A | 1.54e-06 | 1014 | 289 | 25 | 32416067 | |
| Pubmed | Amyloid-β Receptors: The Good, the Bad, and the Prion Protein. | 2.26e-06 | 4 | 289 | 3 | 26719327 | |
| Pubmed | AMPA receptor subunits expressed by single astrocytes in the juvenile mouse hippocampus. | 2.26e-06 | 4 | 289 | 3 | 9221927 | |
| Pubmed | Interaction proteomics reveals brain region-specific AMPA receptor complexes. | 2.26e-06 | 4 | 289 | 3 | 25337787 | |
| Pubmed | Auditory sensitivity regulation via rapid changes in expression of surface AMPA receptors. | 2.26e-06 | 4 | 289 | 3 | 17828255 | |
| Pubmed | 2.26e-06 | 4 | 289 | 3 | 22572802 | ||
| Pubmed | AMPA receptors regulate dynamic equilibrium of presynaptic terminals in mature hippocampal networks. | 2.26e-06 | 4 | 289 | 3 | 12692557 | |
| Pubmed | 2.26e-06 | 4 | 289 | 3 | 11138012 | ||
| Pubmed | Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology. | 2.26e-06 | 4 | 289 | 3 | 31833031 | |
| Pubmed | 2.26e-06 | 4 | 289 | 3 | 14561864 | ||
| Pubmed | 2.26e-06 | 4 | 289 | 3 | 9770464 | ||
| Pubmed | 2.26e-06 | 4 | 289 | 3 | 9267806 | ||
| Pubmed | Deletion of Interstitial Genes between TMPRSS2 and ERG Promotes Prostate Cancer Progression. | 2.26e-06 | 4 | 289 | 3 | 26880803 | |
| Pubmed | 2.26e-06 | 4 | 289 | 3 | 24652293 | ||
| Pubmed | 2.26e-06 | 4 | 289 | 3 | 12125045 | ||
| Pubmed | 2.26e-06 | 4 | 289 | 3 | 10688364 | ||
| Pubmed | 2.26e-06 | 4 | 289 | 3 | 17409242 | ||
| Pubmed | 2.26e-06 | 4 | 289 | 3 | 10458595 | ||
| Pubmed | 2.26e-06 | 4 | 289 | 3 | 29915039 | ||
| Pubmed | 2.26e-06 | 4 | 289 | 3 | 1319477 | ||
| Pubmed | 2.26e-06 | 4 | 289 | 3 | 29720243 | ||
| Pubmed | 2.26e-06 | 4 | 289 | 3 | 9648857 | ||
| Pubmed | GTPBP4 VPS4A CHD3 CLPX SSRP1 GNL2 ABHD8 TAF1 ASCC3 EP400 PIK3R3 IYD CHD9 CHD8 P3H4 INTS10 GTF2H1 YEATS4 MTHFR PANK4 ZFP1 EHMT1 RAB11FIP5 TTC39A POLDIP2 OSMR | 2.66e-06 | 1116 | 289 | 26 | 31753913 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | CDR2 ERCC3 RPS6KA1 RPS6KA2 RPS6KA3 MET NOMO2 VAV3 POGLUT2 MAP3K7 PLOD1 PCDH18 AFF3 BRSK2 GRIA2 ACAD10 CCNA2 NOMO1 GTF2H1 YEATS4 BRSK1 FYN NOMO3 | 2.73e-06 | 910 | 289 | 23 | 36736316 |
| Pubmed | CNKSR1 ETS2 SPART CHD3 ANKRD27 STRN ASCC3 HERC1 DYNC1H1 CPXM2 VPS8 RGS3 DHX30 NOMO1 ARHGAP5 VPS41 NOMO3 INVS | 2.77e-06 | 591 | 289 | 18 | 15231748 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | GTPBP4 ERCC3 CENPC MYO9B DHX38 CHD3 SSRP1 MAP3K5 TAF1 DYNC1H1 TNPO2 CHD9 CHD8 GTF2H1 POLR3B YEATS4 RPL3 | 2.85e-06 | 533 | 289 | 17 | 30554943 |
| Pubmed | RALGAPA1 RPS6KA1 RPS6KA2 RPS6KA3 CHD3 BLM PTPN11 GLA XPO6 PLOD1 TNPO2 P3H4 NOMO1 PANK4 RAB11FIP5 UGGT2 PRMT3 | 2.85e-06 | 533 | 289 | 17 | 25544563 | |
| Pubmed | 3.15e-06 | 13 | 289 | 4 | 31841517 | ||
| Pubmed | 3.30e-06 | 107 | 289 | 8 | 11347906 | ||
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | CNTNAP3B B4GALT7 TCEAL4 CNTNAP3 MGLL NUP205 BLM MET PTPN11 C5 HERC1 GPAT4 KYNU WDR83 CHD8 ACAD10 S1PR3 P3H4 TGFBI MROH1 VPS41 UGGT2 ATM OSMR TMEM68 | 3.43e-06 | 1061 | 289 | 25 | 33845483 |
| Pubmed | NUP58 NEB ASAP1 MAP3K5 SH3BP4 S100A8 VAV3 TAF1 MAP3K7 TCF20 SYNE1 CHD8 N4BP2 ITSN2 EIF3A ZHX1 | 3.76e-06 | 486 | 289 | 16 | 20936779 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | VPS4A TCEAL4 DHX38 CLPX FEM1C NUP205 S100A8 STRN GLA USP38 GNL2 ASCC3 USP3 UNC13B STRN3 RBM45 SGTA CAT CCNA2 NMD3 POLR3B UGGT2 EIF3A DDX39A | 4.32e-06 | 1005 | 289 | 24 | 19615732 |
| Pubmed | ATP7A RNLS ZBTB48 ERAP1 RAPGEF5 TCEAL4 UGGT1 CD109 MGLL NUP58 CCDC122 NEB BLM LPIN1 S100A8 GNPDA2 TAF1 UNC13B ZNF573 GRIA2 RGS3 CCNA2 TTC23 ZNF92 ZFP1 TMPRSS2 OSMR INVS | 4.34e-06 | 1293 | 289 | 28 | 15342556 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | RALGAPA1 IQGAP2 NMRAL1 ASAP1 STRN DYNC1H1 KALRN SYNE1 GRIA1 GRIA2 GRIN2A GRIN2B | 4.74e-06 | 281 | 289 | 12 | 28706196 |
| Pubmed | ERCC3 IQGAP2 UGGT1 SPART COG6 NOMO2 CLUH CDCA7L DYNC1H1 TNPO2 LETM1 INTS10 POLR3B NAMPT PANK4 EHMT1 PRMT3 | 5.48e-06 | 560 | 289 | 17 | 35241646 | |
| Pubmed | Cloning and characterization of a novel class II phosphoinositide 3-kinase containing C2 domain. | 5.61e-06 | 5 | 289 | 3 | 9514948 | |
| Pubmed | PSD-95 stabilizes NMDA receptors by inducing the degradation of STEP61. | 5.61e-06 | 5 | 289 | 3 | 27457929 | |
| Pubmed | 5.61e-06 | 5 | 289 | 3 | 25800971 | ||
| Pubmed | 5.61e-06 | 5 | 289 | 3 | 16190898 | ||
| Pubmed | Reelin signaling facilitates maturation of CA1 glutamatergic synapses. | 5.61e-06 | 5 | 289 | 3 | 17229826 | |
| Pubmed | 5.61e-06 | 5 | 289 | 3 | 10480933 | ||
| Pubmed | RNF220 is an E3 ubiquitin ligase for AMPA receptors to regulate synaptic transmission. | 5.61e-06 | 5 | 289 | 3 | 36179027 | |
| Pubmed | 5.61e-06 | 5 | 289 | 3 | 16129400 | ||
| Pubmed | 5.61e-06 | 5 | 289 | 3 | 16217014 | ||
| Pubmed | 5.61e-06 | 5 | 289 | 3 | 9915826 | ||
| Pubmed | 5.61e-06 | 5 | 289 | 3 | 9482932 | ||
| Pubmed | 5.61e-06 | 5 | 289 | 3 | 15867353 | ||
| Pubmed | Transferrin Receptor Controls AMPA Receptor Trafficking Efficiency and Synaptic Plasticity. | 5.93e-06 | 15 | 289 | 4 | 26880306 | |
| Pubmed | 5.93e-06 | 15 | 289 | 4 | 15509711 | ||
| Pubmed | GTPBP4 ATP7A ELMOD2 PDGFRA CNST ERAP1 MYO9B CTSC DHX38 ANKRD27 NUP205 GNL2 ASCC3 GPAT4 DYNC1H1 DOCK2 CAT CHST11 OGFOD3 NOMO1 NMD3 CEP41 IFT122 EIF3A DDX39A ENO1 | 5.98e-06 | 1168 | 289 | 26 | 19946888 | |
| Pubmed | GTPBP4 SSRP1 NUP205 CDCA7L EP400 CHD8 ZAP70 DHX30 YEATS4 EIF3A | 6.03e-06 | 195 | 289 | 10 | 19454010 | |
| Pubmed | 6.03e-06 | 116 | 289 | 8 | 30804394 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | CDR2 ANKS6 IQGAP2 VPS4A CCDC122 SSRP1 NUP205 SH3BP4 BLM STRN GLA XPO6 CLUH DYNC1H1 RADX RALGPS2 WDR83 DYNLT3 DHX30 NOMO1 LPIN3 GTF2H1 YEATS4 TTC21B UGGT2 IFT122 INVS ZC3HAV1 | 6.47e-06 | 1321 | 289 | 28 | 27173435 |
| Pubmed | GTPBP4 IQGAP2 RPS6KA2 MAP3K5 TWF1 STRN DYNC1H1 CNTN4 STRN3 TCF20 KALRN SYNE1 GRIA1 GRIA2 GRIA4 CHD8 GRIN2A GRIN2B LETM1 N4BP2 EHMT1 BRSK1 ENO1 | 6.87e-06 | 963 | 289 | 23 | 28671696 | |
| Pubmed | 7.86e-06 | 16 | 289 | 4 | 30466882 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | RALGAPA1 RPS6KA2 RTN3 MGLL CHD3 PFKFB1 PTEN SH3BP4 FGF13 DHRSX ARHGAP8 PLOD1 USP3 ARAP1 SGTA PIK3R3 AFF3 CHD9 CHST11 ZNF33A ZNF33B PANK4 VPS41 TTC21B EHMT1 TMPRSS2 IFT122 FGGY INVS ZC3HAV1 | 8.00e-06 | 1489 | 289 | 30 | 28611215 |
| Pubmed | IQGAP2 RPS6KA2 MAP3K5 DYNC1H1 KALRN SYNE1 GRIA1 GRIA2 GRIA4 GRIN2A GRIN2B | 9.27e-06 | 251 | 289 | 11 | 27507650 | |
| Interaction | RYR3 interactions | 8.25e-07 | 24 | 285 | 6 | int:RYR3 | |
| Interaction | AGAP2 interactions | RALGAPA1 IQGAP2 NMRAL1 ASAP1 STAT5A STRN DYNC1H1 KALRN SYNE1 GRIA1 GRIA2 GRIN2A GRIN2B | 9.79e-06 | 210 | 285 | 13 | int:AGAP2 |
| GeneFamily | Lipins | 1.18e-06 | 3 | 192 | 3 | 1043 | |
| GeneFamily | Mitogen-activated protein kinase-activated protein kinases | 3.84e-06 | 11 | 192 | 4 | 1156 | |
| GeneFamily | Glutamate ionotropic receptor AMPA type subunits | 4.68e-06 | 4 | 192 | 3 | 1200 | |
| GeneFamily | UDP-glucose glycoprotein glucosyltransferases | 1.12e-04 | 2 | 192 | 2 | 440 | |
| GeneFamily | Cadherin related | 7.18e-04 | 17 | 192 | 3 | 24 | |
| GeneFamily | SH2 domain containing | 7.29e-04 | 101 | 192 | 6 | 741 | |
| GeneFamily | Ankyrin repeat domain containing | 1.15e-03 | 242 | 192 | 9 | 403 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 2.02e-03 | 24 | 192 | 3 | 654 | |
| GeneFamily | Glutamate ionotropic receptor NMDA type subunits | 2.27e-03 | 7 | 192 | 2 | 1201 | |
| Coexpression | GSE9037_WT_VS_IRAK4_KO_BMDM_UP | RALGAPA1 PDGFRA CHD3 NUP58 CCDC122 FEM1C RMC1 FAT4 OGFOD3 TGFBI ZFP1 TTC39A | 2.49e-06 | 200 | 289 | 12 | M5812 |
| Coexpression | GSE20152_SPHK1_KO_VS_HTNFA_OVEREXPRESS_ANKLE_DN | SSRP1 NUP205 HSD17B4 CLUH TCF20 SYNE1 PIK3R3 CHD8 CHST11 CCNA2 ZNF33B | 1.29e-05 | 197 | 289 | 11 | M7683 |
| Coexpression | GSE33424_CD161_HIGH_VS_NEG_CD8_TCELL_DN | SSRP1 LPIN1 SATB1 FGF13 USP3 TCF20 VPS26B PRC1 ZAP70 CCNA2 FYN | 1.42e-05 | 199 | 289 | 11 | M8542 |
| Coexpression | ENK_UV_RESPONSE_EPIDERMIS_DN | GTPBP4 ATP7A RPS6KA2 RPS6KA3 RTN3 CLPX BNC1 SATB1 GNL2 VAV3 HERC1 HSD17B4 USP3 PRC1 TGFBI NAMPT VPS41 FYN | 1.76e-05 | 512 | 289 | 18 | M4508 |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | GGNBP2 ABCA3 PDGFRA CD109 PLXNB2 ASAP1 GLA PLEKHM2 POGLUT2 PLOD1 IGSF3 CLSTN1 RGS3 KRIT1 DHX30 RPL3 | 5.42e-05 | 457 | 289 | 16 | M1613 |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | GGNBP2 ABCA3 PDGFRA CD109 PLXNB2 ASAP1 GLA PLEKHM2 POGLUT2 PLOD1 IGSF3 CLSTN1 RGS3 KRIT1 DHX30 RPL3 | 7.53e-05 | 470 | 289 | 16 | MM1053 |
| Coexpression | GSE32986_GMCSF_AND_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_UP | RPS6KA1 RTN3 HERC1 POGLUT2 PRC1 YEATS4 MROH1 VPS41 EHMT1 RAB11FIP5 | 7.78e-05 | 199 | 289 | 10 | M8639 |
| Coexpression | GSE40273_XBP1_KO_VS_WT_TREG_DN | ABCA3 CCDC122 PLXNB2 ME3 HERC1 ARHGAP8 DYRK3 SYNE1 LRRK1 S1PR3 | 7.78e-05 | 199 | 289 | 10 | M9124 |
| Coexpression | GSE40441_NRP1_POS_INDUCED_TREG_VS_NRP1_NEG_NATURAL_TREG_DN | AGPAT4 RCBTB2 MGLL NUP58 SATB1 ZMYND12 ARV1 RALGPS2 SPATA1 DNAI1 | 7.78e-05 | 199 | 289 | 10 | M9195 |
| Coexpression | GSE13493_CD4INTCD8POS_VS_CD8POS_THYMOCYTE_UP | ATP7A CCDC122 PTEN MAP3K5 GREB1L SATB1 RPS6KA6 CAPN3 RALGPS2 TMEM68 | 8.11e-05 | 200 | 289 | 10 | M3316 |
| Coexpression | GSE26351_WNT_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_DN | GGNBP2 ZBTB48 MAP3K5 TWF1 FGF13 DYNLT3 OGFOD3 NMD3 TMEM68 ENDOG | 8.11e-05 | 200 | 289 | 10 | M8480 |
| Coexpression | GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN | IQGAP2 RPS6KA2 UGGT1 CHD3 CCDC122 MET VILL DOCK2 TTC39A ENO1 | 8.11e-05 | 200 | 289 | 10 | M7526 |
| Coexpression | GSE3982_DC_VS_CENT_MEMORY_CD4_TCELL_UP | CTSC AGPAT4 TLR7 PLXNB2 HSD17B4 PLOD1 KYNU CHST11 TGFBI VPS41 | 8.11e-05 | 200 | 289 | 10 | M5476 |
| Coexpression | GSE40274_GATA1_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | STAT5A VAV3 GPAT4 PIK3R3 NAMPT N4BP2 LPIN2 EHMT1 IFT122 DDX39A | 8.11e-05 | 200 | 289 | 10 | M9165 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000 | ARHGAP42 GTPBP4 BNC2 ZNF845 GIN1 NUP58 MAP3K5 NUP205 BLM BNC1 FMN1 SGO2 HFM1 MAP3K15 TAF1 HERC1 RMC1 FAM135A DOCK3 ARV1 DYNLT2 TEX14 SPATA1 POLR3B CEP41 KCNK5 PRMT3 ATM CFAP61 FGGY | 5.89e-07 | 810 | 286 | 30 | gudmap_dev gonad_e13.5_M_GermCell_Oct_1000 |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | CNTNAP3B CTSC CNTNAP3 LPIN1 FGF13 VAV3 DOCK2 DOCK3 GRIA1 CHST11 GRIN2B ZAP70 | 2.35e-09 | 179 | 289 | 12 | 14fc8ccb6b215063d747643f47d780d2b237eb67 |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RYR3 PIK3C2G DTHD1 CNTN4 DNAH10 GRIA4 GRIN2B SIM2 PKHD1L1 TRAPPC3L UNC5C | 8.45e-09 | 160 | 289 | 11 | c381ec6be8cf887861cc18f831a20db42f953fe1 |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RYR3 PIK3C2G DTHD1 CNTN4 DNAH10 GRIA4 GRIN2B SIM2 PKHD1L1 TRAPPC3L UNC5C | 8.45e-09 | 160 | 289 | 11 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | RNLS CFAP54 DTHD1 CDCA7L BBOF1 CFAP47 IQCH DNAH10 DNAI1 CFAP61 CFAP46 | 4.73e-08 | 189 | 289 | 11 | 3e77883db34722b9ce0a03ea74caefc92dc7feff |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | ARHGAP42 PDGFRA MAP3K5 PCDH18 CNTN4 FAT4 HTR2B AFF3 ABCC9 S1PR3 UNC5C | 5.00e-08 | 190 | 289 | 11 | 2e592323085ba9c019d678ac2a784462ab470ed9 |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | ARHGAP42 PDGFRA MAP3K5 PCDH18 CNTN4 FAT4 HTR2B AFF3 ABCC9 S1PR3 UNC5C | 5.00e-08 | 190 | 289 | 11 | 445952b70abffadb6ccc1ed4bbf61a88b06b73b3 |
| ToppCell | COPD-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | RNLS CFAP54 DTHD1 CDCA7L BBOF1 CFAP47 IQCH DNAH10 DNAI1 CFAP61 CFAP46 | 5.56e-08 | 192 | 289 | 11 | eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | RAPGEF5 RPS6KA2 CD109 CCDC178 RYR3 ASAP1 ADGRL4 CPXM2 PIK3R3 PKHD1L1 OSMR | 5.86e-08 | 193 | 289 | 11 | c0973a2c97deb7176c2f617c8760a55f7edc9839 |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | RNLS CFAP54 DTHD1 BBOF1 CFAP47 IQCH DNAH10 SYNE1 DNAI1 CFAP61 CFAP46 | 5.86e-08 | 193 | 289 | 11 | ad58f5080e0ba65c845056ea6b79037b636e9c64 |
| ToppCell | COVID-19-Myeloid-Transitioning_MDM|COVID-19 / group, cell type (main and fine annotations) | IQGAP2 MYO9B ETS2 FMN1 VAV3 KYNU DOCK2 VPS8 CHST11 TGFBI NAMPT | 6.86e-08 | 196 | 289 | 11 | 4929cfed1f150c1fde4d79cb49895c2ea467a18f |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | ARHGAP42 ATP7A PDGFRA MYO9B RAPGEF5 PCDH18 HTR2B SYNE1 S1PR3 UNC5C | 2.30e-07 | 175 | 289 | 10 | 12f5fd83c7710fc0c77406f765d9cbd133433b8b |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | CCDC178 PFKFB1 ME3 PIK3C2G FMN1 FGF13 MAP3K15 CPXM2 SIM1 UNC5C | 3.31e-07 | 182 | 289 | 10 | 5f513bbb7125956eb528e3120de3fd776770a7c3 |
| ToppCell | pdx-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | CNTNAP3B CTSC CNTNAP3 LPIN1 FGF13 DOCK2 GRIA1 CHST11 GRIN2B ZAP70 | 3.31e-07 | 182 | 289 | 10 | 7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | CCDC178 PFKFB1 ME3 PIK3C2G FMN1 FGF13 MAP3K15 CPXM2 SIM1 UNC5C | 3.48e-07 | 183 | 289 | 10 | 2e831a4d99c6f983793df71c0994124c943c6da9 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | NEB RYR3 PIK3C2G ADAMTS20 FAT4 DNAH10 KALRN GRIN2B PKHD1L1 MYO15A | 3.66e-07 | 184 | 289 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | NEB RYR3 PIK3C2G ADAMTS20 FAT4 DNAH10 KALRN GRIN2B PKHD1L1 MYO15A | 3.66e-07 | 184 | 289 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | NEB RYR3 PIK3C2G ADAMTS20 FAT4 DNAH10 KALRN GRIN2B PKHD1L1 MYO15A | 3.66e-07 | 184 | 289 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | Control-T_cells-CD8+_T_cells|Control / group, cell type (main and fine annotations) | IQGAP2 APOBEC3G VAV3 DTHD1 DOCK2 CHST11 ZAP70 ATM FYN ZC3HAV1 | 3.85e-07 | 185 | 289 | 10 | 02ab64c0166c0646d1d4c6ed110ef0b75a1096d0 |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.47e-07 | 188 | 289 | 10 | bc089cd73d283ed7d2ecbb3936673b4edc89f666 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.47e-07 | 188 | 289 | 10 | eec3d353e51358db4c7621265ee0fdd4298e5b0e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | RAPGEF5 RPS6KA2 ASAP1 BNC1 CFAP54 KALRN GRIA1 GRIN2B PKHD1L1 CATSPERB | 4.92e-07 | 190 | 289 | 10 | 876bd2eb9ed2624cb23bdcf6b989e4fa34d099e3 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | RAPGEF5 RPS6KA2 ASAP1 BNC1 CFAP54 KALRN GRIA1 GRIN2B PKHD1L1 CATSPERB | 4.92e-07 | 190 | 289 | 10 | 09a8855901c3c9332dbaab3e40166485b696d0f1 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | RAPGEF5 RPS6KA2 ASAP1 BNC1 CFAP54 KALRN GRIA1 GRIN2B PKHD1L1 CATSPERB | 4.92e-07 | 190 | 289 | 10 | be9f36127028f52ca5fc1b32ba15a6c26aad69ac |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | RNLS CFAP54 DTHD1 BBOF1 CFAP47 IQCH DNAH10 DNAI1 CFAP61 CFAP46 | 5.16e-07 | 191 | 289 | 10 | 1c528f72c9ef3ef3a850b05e4a9715190832270c |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | RNLS CFAP54 DTHD1 BBOF1 CFAP47 IQCH DNAH10 DNAI1 CFAP61 CFAP46 | 5.16e-07 | 191 | 289 | 10 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | RNLS CFAP54 DTHD1 BBOF1 CFAP47 IQCH DNAH10 DNAI1 CFAP61 CFAP46 | 5.16e-07 | 191 | 289 | 10 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b |
| ToppCell | IPF-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | RNLS CFAP54 DTHD1 BBOF1 CFAP47 IQCH DNAH10 DNAI1 CFAP61 CFAP46 | 5.42e-07 | 192 | 289 | 10 | d903bbd6c18e29e2c4cdedeb3fea1fd5ad7baa11 |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | RNLS CFAP54 DTHD1 BBOF1 CFAP47 IQCH DNAH10 DNAI1 CFAP61 CFAP46 | 5.42e-07 | 192 | 289 | 10 | 354adc1354bf596fbc60dd45c0169688e6f45165 |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | RNLS CFAP54 DTHD1 BBOF1 CFAP47 IQCH DNAH10 DNAI1 CFAP61 CFAP46 | 5.68e-07 | 193 | 289 | 10 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e |
| ToppCell | RA-08._Macrophage|World / Chamber and Cluster_Paper | 5.68e-07 | 193 | 289 | 10 | 5fd22db1825d105709fcc0aa4955c99a117e3c82 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | ARHGAP42 PDGFRA PTEN ASAP1 MAP3K5 NALCN AFF3 ABCC9 GRIN2A OSMR | 6.54e-07 | 196 | 289 | 10 | 2b36b9a40fe415917afccff99ad9c3474e087d0d |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | ARHGAP42 RAPGEF5 PTEN ASAP1 MAP3K5 NALCN AFF3 ABCC9 GRIN2A UNC5C | 6.85e-07 | 197 | 289 | 10 | 80e153790cef37b743e22a7370ff5b3a6abf147d |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)-D231|Adult / Lineage, Cell type, age group and donor | 7.18e-07 | 198 | 289 | 10 | 79a415e19cedde13a88f5043d71557363f102322 | |
| ToppCell | COVID-19-Myeloid|COVID-19 / group, cell type (main and fine annotations) | 7.18e-07 | 198 | 289 | 10 | 33f0a919188a67d2a876b52c61a1cec2c9747969 | |
| ToppCell | healthy_donor-Lymphocytic-ILC-NK_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 7.18e-07 | 198 | 289 | 10 | d7053a898e04478c577381085f615edaad3cdc5b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.18e-07 | 198 | 289 | 10 | 92416e65a0dc1a4bf931833407620ea05d362f56 | |
| ToppCell | healthy_donor-Lymphocytic-ILC|healthy_donor / Disease condition, Lineage, Cell class and subclass | 7.18e-07 | 198 | 289 | 10 | aa33be29e26f1b8facfc894413099083ae3bbb1b | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK|Control / Disease, condition lineage and cell class | 7.87e-07 | 200 | 289 | 10 | c64c27dbf4df42ca2ad2bd94b50fab87b4050ef3 | |
| ToppCell | Control_saline-Mesenchymal_myocytic|Control_saline / Treatment groups by lineage, cell group, cell type | ARHGAP42 FNDC1 PCDH18 DOCK3 SFRP4 SYNE1 ABCC9 S1PR3 TGFBI RERGL | 7.87e-07 | 200 | 289 | 10 | 5ed4261157cd51109b314818133ac3a0d34ee5fa |
| ToppCell | mild-NK|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.87e-07 | 200 | 289 | 10 | a11fb1d7e124c352eb73fea0e0ec0fed577c97f7 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | MYO9B RPS6KA1 CD109 STAT5A PLEKHM2 GPAT4 KYNU ARAP1 TGFBI ENO1 | 7.87e-07 | 200 | 289 | 10 | 851c57187db8bc91a393655bca5f13e787a723d4 |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-mature_NK_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-06 | 159 | 289 | 9 | 4000ed0d3b7d488722bcd0042fa2ff4405aaab82 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-Natural_Killer_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-06 | 159 | 289 | 9 | 7619d0d49738dd08daf01b42664691a5323aa793 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.03e-06 | 173 | 289 | 9 | 0c74bdb40e635d906fd180412c23bf7fed61621e | |
| ToppCell | droplet-Heart-HEART-1m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-06 | 173 | 289 | 9 | 9dc7746a84f0e268a7c061e1bbcd5e31903034dc | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-06 | 175 | 289 | 9 | 09163e7030f76d706eccabdb1d5ec45f8412aa75 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-06 | 175 | 289 | 9 | 0801cccec6915aefc135262fc74580280fd51aa5 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.34e-06 | 176 | 289 | 9 | 3bbac5c2397535631fce8fa98f6ddb4fe0260351 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.45e-06 | 177 | 289 | 9 | dc846d0feb94d4c289553cc3ac9dac81d10409cb | |
| ToppCell | COVID-19-Heart-Lymph_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | CNTNAP3B RAPGEF5 CNTNAP3 NALCN VAV3 KALRN GRIN2B PKHD1L1 CATSPERB | 2.45e-06 | 177 | 289 | 9 | 326fde0734ef0d7272693966d346ca479b9d8147 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.69e-06 | 179 | 289 | 9 | 666072c0e8448dbaec1683d18368ec2502453f90 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.81e-06 | 180 | 289 | 9 | 280ff5c8f292be1b88120db5ff1788b750644856 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.81e-06 | 180 | 289 | 9 | fdbd7c22044d9328a1e06e2f9a4451529d1df767 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.88e-06 | 135 | 289 | 8 | 4451c44f3ad788437f4e2ae81049fbbab53f967e | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.88e-06 | 135 | 289 | 8 | 45f67f33c8320d9fb6dbceae603b564f6a8ffd1e | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 3.08e-06 | 182 | 289 | 9 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | COPD-Epithelial-ATII|World / Disease state, Lineage and Cell class | 3.22e-06 | 183 | 289 | 9 | 8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 3.37e-06 | 184 | 289 | 9 | d2bf0135eb56bb410997dccea39c5ede88a0617f | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-06 | 185 | 289 | 9 | 05bc89a566b0db90ae06506e067190a4739a0974 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | ABCA3 RAPGEF5 RPS6KA2 MET PIK3C2G FMN1 HSD17B4 UNC13B TMPRSS2 | 3.84e-06 | 187 | 289 | 9 | 5df9e1f5ca32217af255e76e6fb5afa346337811 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.84e-06 | 187 | 289 | 9 | 77886f99c229610abd28c4c370d2c7d1536c9782 | |
| ToppCell | COVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type | 4.02e-06 | 188 | 289 | 9 | df1fd0819d301679f3c9ea404e942e39095912eb | |
| ToppCell | COVID-19-kidney-DCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | CCDC178 PIK3C2G RPS6KA6 FGF13 MAP3K15 IGSF3 CPXM2 SIM1 FAM83B | 4.02e-06 | 188 | 289 | 9 | 1d56cd409793f05cca20757ab26e91f1a1ee67b5 |
| ToppCell | Macrophages-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 4.19e-06 | 189 | 289 | 9 | c05b4b565c0ce56dbb45fc9503654a2ec1a7e1e9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.19e-06 | 189 | 289 | 9 | 7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917 | |
| ToppCell | Adult|World / Lineage, Cell type, age group and donor | 4.19e-06 | 189 | 289 | 9 | 5cd285bfad973125d46d704fec18b21266a63379 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.19e-06 | 189 | 289 | 9 | f51cdc9a47371cab8ed9ae63a6f14da07ede446c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.19e-06 | 189 | 289 | 9 | 977a813e5d7a5a561c1fced2bbf21c20056b88d8 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.19e-06 | 189 | 289 | 9 | c734e5693808a0333139e87bd5be2597a9252afe | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.38e-06 | 190 | 289 | 9 | bf4511395fa97efd1c1cd17cc9bebb0271ee7f0e | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | CNTNAP3B CNTNAP3 NALCN VAV3 KALRN GRIN2B PKHD1L1 RAB11FIP5 CATSPERB | 4.38e-06 | 190 | 289 | 9 | 6e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7 |
| ToppCell | Control-Myeloid-Transitioning_MDM|Control / group, cell type (main and fine annotations) | 4.38e-06 | 190 | 289 | 9 | d6fd8c23cde4a10cc1517b6899a5a855fdfff2e2 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.38e-06 | 190 | 289 | 9 | e252e925600e6457fa6e362a55217f4cffa75cdb | |
| ToppCell | COVID-19-lung-Vein_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.38e-06 | 190 | 289 | 9 | 1caeaef78326734c1e31a0c4739190d5c5a77b9e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.38e-06 | 190 | 289 | 9 | b6b8964b4910083499681b5fdf554e127b6a4c4e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.57e-06 | 191 | 289 | 9 | c54c420a94dc749ebc67fc64c5614663f4b9798d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.57e-06 | 191 | 289 | 9 | 2fa1b9e76a0ed2d2f0de74349e266cf4a5f51aad | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.57e-06 | 191 | 289 | 9 | 08042952431ca1a6fd7dfc13f36eb28643979598 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.57e-06 | 191 | 289 | 9 | cb0aee740b08f7d5fdd2717ecf7429043b277ae7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.77e-06 | 192 | 289 | 9 | bc84b9ce01b4d826a682842ab8a395dac9b91183 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 4.77e-06 | 192 | 289 | 9 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-NK|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.77e-06 | 192 | 289 | 9 | a06d5d3c2537f8d2b1dc6b6f3e88a80b5c2a1850 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.77e-06 | 192 | 289 | 9 | 0ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.97e-06 | 193 | 289 | 9 | 08696a99309f5b088692ddac8cca35413b5e810d | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)|Adult / Lineage, Cell type, age group and donor | 4.97e-06 | 193 | 289 | 9 | 31c0978ba78c9516d498aec0798902e57555e557 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.97e-06 | 193 | 289 | 9 | 456aa8a8f1f9cbba0bd618a5f623909079c0f56b | |
| ToppCell | Children_(3_yrs)-Immune-natural_killer_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.97e-06 | 193 | 289 | 9 | 1cb666375bc4e1b11a146d20896c9b5ae6fd0887 | |
| ToppCell | COVID-19-lung-NK/NKT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.97e-06 | 193 | 289 | 9 | c24b44fcc92fff42ebba6f1aff91c7aaea179e56 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.18e-06 | 194 | 289 | 9 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.18e-06 | 194 | 289 | 9 | 240d122dcb9dd1ab2867503ad85869853adcacae | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_NK-natural_killer_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.18e-06 | 194 | 289 | 9 | a3a81638b55cb5fc08fe83c8b88f68d49b87e6cb | |
| ToppCell | Control-Lymphoid-pDC|Lymphoid / Condition, Lineage and Cell class | 5.18e-06 | 194 | 289 | 9 | 5f95a5a35f73222dbe2ca52cc580f4774f641403 | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D231|Adult / Lineage, Cell type, age group and donor | 5.18e-06 | 194 | 289 | 9 | 800d3d7a9e864d2d6a100a4e4af22f45d5790a8d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.18e-06 | 194 | 289 | 9 | ae7df037592f1c20c9d32be15fe6fc3c562ebeb1 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_NK-natural_killer_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.18e-06 | 194 | 289 | 9 | 0abca32c3547a45cebab0bd69c1f7a0002deaa80 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | CNTNAP3B RAPGEF5 AGPAT4 ETS2 ASAP1 ADGRL4 SYNE1 PKHD1L1 CATSPERB | 5.18e-06 | 194 | 289 | 9 | ad6c04ad0621689e3bf4c94ccd6e60653bbd02c7 |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.18e-06 | 194 | 289 | 9 | f95c8dc242c9aebcadfe61b1ed033349cb7e5a88 | |
| ToppCell | RA-08._Macrophage|RA / Chamber and Cluster_Paper | 5.18e-06 | 194 | 289 | 9 | ac26e5c71d5069622de72fa25a9c920887ac2c19 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 5.40e-06 | 195 | 289 | 9 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|lung / Disease (COVID-19 only), tissue and cell type | 5.40e-06 | 195 | 289 | 9 | 148fff8c3c9ba45ec36e98dff1be57e3f8294506 | |
| Drug | YM90K | 3.28e-07 | 23 | 288 | 6 | CID005486547 | |
| Drug | gavestinel | 5.63e-07 | 25 | 288 | 6 | CID006450546 | |
| Drug | AD 288 | 5.70e-07 | 14 | 288 | 5 | CID000073553 | |
| Drug | thiokynurenic acid | 8.47e-07 | 15 | 288 | 5 | CID003035667 | |
| Drug | SAR 020106 | 8.52e-07 | 7 | 288 | 4 | ctd:C547874 | |
| Drug | LY233536 | 1.22e-06 | 16 | 288 | 5 | CID000126239 | |
| Drug | everolimus | ERCC3 PDGFRA RPS6KA1 RPS6KA2 RPS6KA3 PTEN GLA PIK3C2G RPS6KA6 PIK3R3 ATM | 1.32e-06 | 136 | 288 | 11 | CID006442177 |
| Drug | wartmannin | PDGFRA MYO9B RPS6KA1 RPS6KA2 RPS6KA3 ETS2 PFKFB1 PTEN STAT5A ADGRL4 MET PTPN11 FCGR3A FCGR3B PIK3C2G MYO3B RPS6KA6 DOCK2 HTR2B PIK3R3 S1PR3 TGFBI EHMT1 ATM MYO15A FYN RPL3 ZHX1 | 1.68e-06 | 811 | 288 | 28 | CID000005691 |
| Drug | 1-hydroxypyrazole | 1.69e-06 | 8 | 288 | 4 | CID003016733 | |
| Drug | 1-hydroxyimidazole | 1.69e-06 | 8 | 288 | 4 | CID003614351 | |
| Drug | 7-Cl-Thio-Kyna | 1.71e-06 | 17 | 288 | 5 | CID003035668 | |
| Drug | MNQX | 2.34e-06 | 18 | 288 | 5 | CID000130818 | |
| Drug | D-CPPene | 3.88e-06 | 34 | 288 | 6 | CID006435801 | |
| Drug | IDRA 21 | 4.15e-06 | 20 | 288 | 5 | CID000003688 | |
| Drug | kainite | 4.64e-06 | 35 | 288 | 6 | CID000164810 | |
| Drug | CX546 | 5.39e-06 | 21 | 288 | 5 | CID000002890 | |
| Drug | NS 102 | 6.90e-06 | 22 | 288 | 5 | CID005282252 | |
| Drug | CX516 | 6.90e-06 | 22 | 288 | 5 | CID000148184 | |
| Drug | 4CPG | 7.64e-06 | 38 | 288 | 6 | CID000005115 | |
| Drug | 0-ol | 7.72e-06 | 11 | 288 | 4 | CID000069892 | |
| Drug | BI D1870 | 7.72e-06 | 11 | 288 | 4 | ctd:C516541 | |
| Drug | sunifiram | 7.94e-06 | 4 | 288 | 3 | CID004223812 | |
| Drug | 4-(chloromethyl)-3-methoxy-5-methylisoxazole | 7.94e-06 | 4 | 288 | 3 | CID011105661 | |
| Drug | 3-isoxazolol | 7.94e-06 | 4 | 288 | 3 | CID009964065 | |
| Drug | 3-pyridazinol 1-oxide | 7.94e-06 | 4 | 288 | 3 | CID000574311 | |
| Drug | CGP 39653 | 1.09e-05 | 24 | 288 | 5 | CID006437837 | |
| Drug | Cymal-6 | 1.64e-05 | 13 | 288 | 4 | CID000447688 | |
| Drug | Naspm | 1.64e-05 | 13 | 288 | 4 | CID000129695 | |
| Drug | AC1L1YEG | 1.97e-05 | 5 | 288 | 3 | CID000063114 | |
| Drug | Chicago acid | 1.97e-05 | 5 | 288 | 3 | CID000065740 | |
| Drug | CHEBI:570577 | 1.97e-05 | 5 | 288 | 3 | CID011334126 | |
| Drug | 1-BCP | 1.97e-05 | 5 | 288 | 3 | CID000001370 | |
| Drug | irampanel | 1.97e-05 | 5 | 288 | 3 | CID003038472 | |
| Drug | ciguatoxin 3C | 1.97e-05 | 5 | 288 | 3 | ctd:C466858 | |
| Drug | LY395153 | 1.97e-05 | 5 | 288 | 3 | CID000656707 | |
| Drug | beta-N-oxalylaminoalanine | 1.97e-05 | 5 | 288 | 3 | CID000107978 | |
| Drug | 5-h PCA | 1.97e-05 | 5 | 288 | 3 | CID000129091 | |
| Drug | L-689,560 | 2.01e-05 | 27 | 288 | 5 | CID000121918 | |
| Drug | Ovta | 2.27e-05 | 14 | 288 | 4 | CID003081047 | |
| Drug | C-PP | 2.42e-05 | 28 | 288 | 5 | CID000001228 | |
| Drug | aptiganel | 2.42e-05 | 28 | 288 | 5 | CID000060839 | |
| Drug | AC1NUW3V | 2.90e-05 | 29 | 288 | 5 | CID005462126 | |
| Drug | ketobemidone | 2.90e-05 | 29 | 288 | 5 | CID000010101 | |
| Drug | avermectin | 3.05e-05 | 48 | 288 | 6 | CID006450460 | |
| Drug | cis-2,3-piperidine dicarboxylic acid | 3.44e-05 | 30 | 288 | 5 | CID000001226 | |
| Drug | LY293558 | 3.44e-05 | 30 | 288 | 5 | CID000127894 | |
| Drug | GYKI 53655 | 3.44e-05 | 30 | 288 | 5 | CID000126757 | |
| Drug | AC1L32TU | 3.44e-05 | 30 | 288 | 5 | CID000107831 | |
| Drug | DIMBOA | 3.44e-05 | 49 | 288 | 6 | CID000002358 | |
| Drug | methylenecyclopropylglycine | 3.44e-05 | 49 | 288 | 6 | CID000441452 | |
| Drug | L-CCG-I | 3.87e-05 | 50 | 288 | 6 | CID000001271 | |
| Drug | YM928 | 3.89e-05 | 6 | 288 | 3 | CID006918393 | |
| Drug | 2cmo | 3.89e-05 | 6 | 288 | 3 | CID006914597 | |
| Drug | repinotan | 4.05e-05 | 16 | 288 | 4 | CID000198756 | |
| Drug | R165481 | 4.05e-05 | 16 | 288 | 4 | CID005459348 | |
| Drug | NPC 12626 | 4.06e-05 | 31 | 288 | 5 | CID000108099 | |
| Drug | 4-methylglutamic acid | 4.06e-05 | 31 | 288 | 5 | CID000005365 | |
| Drug | LY235959 | 4.06e-05 | 31 | 288 | 5 | CID000131938 | |
| Drug | eliprodil | 4.06e-05 | 31 | 288 | 5 | CID000060703 | |
| Drug | LY354740 | 4.34e-05 | 51 | 288 | 6 | CID000114827 | |
| Drug | M100907 | 4.34e-05 | 51 | 288 | 6 | CID000060858 | |
| Drug | 2-butenedioate | ERCC3 ETS2 F13B ME3 HTR2B TCF20 GRIA1 GRIA2 GRIA4 CAT GRIN2A GRIN2B | 4.67e-05 | 234 | 288 | 12 | CID000000723 |
| Drug | alpha-methyl-4-carboxyphenylglycine | 4.76e-05 | 32 | 288 | 5 | CID000001222 | |
| Drug | Quinoxaline | 4.86e-05 | 52 | 288 | 6 | CID000007045 | |
| Drug | SB 202190; Up 200; 1uM; PC3; HT_HG-U133A | ERAP1 RAPGEF5 RPS6KA2 DHX38 ETS2 IMPACT RCBTB2 PLEKHM2 ABHD8 DYRK3 KRIT1 | 4.92e-05 | 199 | 288 | 11 | 7058_UP |
| Drug | 1-aminoindan-1,5-dicarboxylic acid | 5.55e-05 | 33 | 288 | 5 | CID000002071 | |
| Drug | 6,7-dinitroquinoxaline | 5.55e-05 | 33 | 288 | 5 | CID002724608 | |
| Drug | DL-Serine | ZBTB48 CYSLTR1 GLA BRSK2 GRIA1 GRIA2 GRIA4 GRIN2A GRIN2B TMPRSS2 BRSK1 | 5.89e-05 | 203 | 288 | 11 | CID000000617 |
| Drug | MDL 28170 | 6.03e-05 | 54 | 288 | 6 | CID000072430 | |
| Drug | 2H-1,2,4-benzothiadiazine | 6.75e-05 | 7 | 288 | 3 | CID000473368 | |
| Drug | 4,6-dichloroindole-2-carboxylic acid | 6.75e-05 | 7 | 288 | 3 | CID000127988 | |
| Drug | thio-ATPA | 6.75e-05 | 7 | 288 | 3 | CID005289517 | |
| Drug | octylmethoxycinnamate | 7.14e-05 | 139 | 288 | 9 | ctd:C118580 | |
| Drug | beta-tyrosine | 7.44e-05 | 35 | 288 | 5 | CID000440311 | |
| Drug | AC1L9OLY | 7.98e-05 | 141 | 288 | 9 | CID000424898 | |
| Drug | PhTX-343 | 8.55e-05 | 36 | 288 | 5 | CID000159548 | |
| Drug | R,S)-AMPA | 8.55e-05 | 36 | 288 | 5 | CID000001221 | |
| Drug | C6H12NO5P | 8.55e-05 | 36 | 288 | 5 | CID000104962 | |
| Drug | gacyclidine | 8.55e-05 | 36 | 288 | 5 | CID000176265 | |
| Drug | glutamic acid diethyl ester | 8.55e-05 | 36 | 288 | 5 | CID000073960 | |
| Drug | selenocystein | 8.89e-05 | 143 | 288 | 9 | CID006326972 | |
| Drug | GYKI 52466 | 9.06e-05 | 58 | 288 | 6 | CID000003538 | |
| Drug | gamma-Glu-Gly | 9.79e-05 | 37 | 288 | 5 | CID000100099 | |
| Drug | KSCN | 9.79e-05 | 37 | 288 | 5 | CID000516872 | |
| Drug | 2-propynylamine | 9.79e-05 | 37 | 288 | 5 | CID000239041 | |
| Drug | CID6451162 | 1.07e-04 | 8 | 288 | 3 | CID006451162 | |
| Drug | homoibotenic acid | 1.07e-04 | 8 | 288 | 3 | CID000194385 | |
| Drug | Intravenous Immunoglobulin | 1.07e-04 | 8 | 288 | 3 | DB00028 | |
| Drug | WT702 | 1.07e-04 | 8 | 288 | 3 | CID000089643 | |
| Drug | 2,3-PDCA | 1.07e-04 | 8 | 288 | 3 | CID000127037 | |
| Drug | ifenprodil | 1.07e-04 | 8 | 288 | 3 | ctd:C010739 | |
| Drug | piperazine-2,3-dicarboxylic acid | 1.07e-04 | 8 | 288 | 3 | CID000280973 | |
| Drug | Iem 1460 | 1.07e-04 | 8 | 288 | 3 | CID003248290 | |
| Drug | 3,5-dihydroxyphenylglycine | 1.10e-04 | 60 | 288 | 6 | CID000108001 | |
| Drug | L-BMAA | 1.12e-04 | 38 | 288 | 5 | CID000028558 | |
| Drug | CGS 19755 | 1.12e-04 | 38 | 288 | 5 | CID000068736 | |
| Drug | GAMs | 1.12e-04 | 38 | 288 | 5 | CID000002935 | |
| Drug | NSC406942 | ZBTB48 GIN1 CLPX RYR3 ME3 GLA DYNC1H1 UNC13B CAPN3 GRIA1 GRIA2 GRIA4 CAT DYNLT2 DNAI1 IFT122 EIF3A RPL3 INVS | 1.17e-04 | 565 | 288 | 19 | CID000001115 |
| Drug | HA-966 | 1.27e-04 | 39 | 288 | 5 | CID000001232 | |
| Drug | DETC-MeSO | 1.27e-04 | 39 | 288 | 5 | CID003035711 | |
| Disease | Coffin-Lowry syndrome (implicated_via_orthology) | 8.17e-09 | 4 | 282 | 4 | DOID:3783 (implicated_via_orthology) | |
| Disease | Intellectual Disability | RALGAPA1 CNKSR1 CHD3 PTEN TAF1 ASCC3 DYNC1H1 TCF20 SYNE1 AFF3 BRSK2 GRIA1 GRIA2 CHD8 GRIN2B LETM1 CCNA2 CAPN10 POLR3B ZNF292 | 1.46e-08 | 447 | 282 | 20 | C3714756 |
| Disease | lipid metabolism disorder (implicated_via_orthology) | 2.14e-07 | 15 | 282 | 5 | DOID:3146 (implicated_via_orthology) | |
| Disease | myoglobinuria (implicated_via_orthology) | 8.64e-07 | 3 | 282 | 3 | DOID:0080108 (implicated_via_orthology) | |
| Disease | Profound Mental Retardation | CNKSR1 PTEN ASCC3 DYNC1H1 CHD8 GRIN2B LETM1 CCNA2 CAPN10 POLR3B | 9.77e-07 | 139 | 282 | 10 | C0020796 |
| Disease | Mental deficiency | CNKSR1 PTEN ASCC3 DYNC1H1 CHD8 GRIN2B LETM1 CCNA2 CAPN10 POLR3B | 9.77e-07 | 139 | 282 | 10 | C0917816 |
| Disease | Mental Retardation, Psychosocial | CNKSR1 PTEN ASCC3 DYNC1H1 CHD8 GRIN2B LETM1 CCNA2 CAPN10 POLR3B | 9.77e-07 | 139 | 282 | 10 | C0025363 |
| Disease | Autistic Disorder | PTEN MET CNTN4 MAGEL2 BRSK2 GRIA1 CAT CHD8 GRIN2A GRIN2B MTHFR RAB11FIP5 ZNF292 | 1.58e-06 | 261 | 282 | 13 | C0004352 |
| Disease | cognitive function measurement | GGNBP2 RAPGEF5 MCF2L2 PLXNB2 RYR3 ME3 ADGRL4 FMN1 FGF13 VAV3 MAP3K7 CDCA7L ARAP1 DOCK3 CNTN4 TCF20 KALRN AFF3 VPS8 GRIA4 GRIN2A GRIN2B TEX14 RGS3 KCNH3 NMD3 TGFBI RERGL ITSN2 TTC21B RAB11FIP5 PRMT3 FYN | 3.05e-06 | 1434 | 282 | 33 | EFO_0008354 |
| Disease | Metastatic melanoma | 1.27e-05 | 54 | 282 | 6 | C0278883 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.67e-05 | 152 | 282 | 9 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Lymphoma | 3.85e-05 | 40 | 282 | 5 | C0024299 | |
| Disease | obesity (implicated_via_orthology) | PLXNB2 LPIN1 ADAMTS20 HSD17B4 FAT4 DNAH10 CAPN3 SIM1 LPIN3 LPIN2 | 4.57e-05 | 215 | 282 | 10 | DOID:9970 (implicated_via_orthology) |
| Disease | NEPHRONOPHTHISIS 2 | 4.67e-05 | 8 | 282 | 3 | C1865872 | |
| Disease | Immunologic Deficiency Syndromes | 6.27e-05 | 23 | 282 | 4 | C0021051 | |
| Disease | plexin-B2 measurement | 6.95e-05 | 9 | 282 | 3 | EFO_0021867 | |
| Disease | Avellino corneal dystrophy | 9.10e-05 | 2 | 282 | 2 | C1275685 | |
| Disease | level of low affinity immunoglobulin gamma Fc region receptor III-A in blood serum | 9.10e-05 | 2 | 282 | 2 | OBA_2040305 | |
| Disease | Macrocephaly | 1.35e-04 | 11 | 282 | 3 | C0221355 | |
| Disease | hyperhomocysteinemia (implicated_via_orthology) | 1.35e-04 | 11 | 282 | 3 | DOID:9279 (implicated_via_orthology) | |
| Disease | Craniofacial Abnormalities | 1.35e-04 | 156 | 282 | 8 | C0376634 | |
| Disease | melanoma | 1.49e-04 | 248 | 282 | 10 | C0025202 | |
| Disease | Colorectal Carcinoma | ABCA3 MCF2L2 CD109 PTEN LPIN1 CPO ADAMTS18 UNC13B CNTN4 SFRP4 KALRN SYNE1 GRIN2A CAPN10 NAMPT MTHFR PANK4 ZNF292 | 1.61e-04 | 702 | 282 | 18 | C0009402 |
| Disease | cutaneous melanoma | 1.69e-04 | 121 | 282 | 7 | EFO_0000389 | |
| Disease | leukemia | 1.81e-04 | 55 | 282 | 5 | C0023418 | |
| Disease | Nephronophthisis | 2.30e-04 | 13 | 282 | 3 | C0687120 | |
| Disease | Fetal Alcohol Spectrum Disorders | 2.30e-04 | 13 | 282 | 3 | C2985290 | |
| Disease | Lupus Vasculitis, Central Nervous System | 2.71e-04 | 3 | 282 | 2 | C0752332 | |
| Disease | Lupus Meningoencephalitis | 2.71e-04 | 3 | 282 | 2 | C0752334 | |
| Disease | Neuropsychiatric Systemic Lupus Erythematosus | 2.71e-04 | 3 | 282 | 2 | C0752335 | |
| Disease | complement C5 measurement | 2.71e-04 | 3 | 282 | 2 | EFO_0020278 | |
| Disease | serine/threonine-protein kinase BRSK2 measurement | 2.71e-04 | 3 | 282 | 2 | EFO_0803063 | |
| Disease | pyridoxamine measurement | 2.71e-04 | 3 | 282 | 2 | EFO_0021837 | |
| Disease | platelet-derived growth factor receptor alpha measurement | 2.71e-04 | 3 | 282 | 2 | EFO_0021844 | |
| Disease | PROSTATE CANCER, HEREDITARY, 1 | 2.74e-04 | 60 | 282 | 5 | C4722327 | |
| Disease | Neurodevelopmental Disorders | 2.75e-04 | 93 | 282 | 6 | C1535926 | |
| Disease | Malignant neoplasm of breast | ABCA3 ERCC3 RPS6KA3 MCF2L2 CD109 ETS2 PTEN FEM1C STAT5A PLOD1 KALRN SYNE1 MANEA CAT SIM1 PRC1 MTHFR N4BP2 ITSN2 EHMT1 ATM CLUL1 ENO1 | 2.91e-04 | 1074 | 282 | 23 | C0006142 |
| Disease | Adenocarcinoma of large intestine | 3.26e-04 | 96 | 282 | 6 | C1319315 | |
| Disease | central nervous system disease (implicated_via_orthology) | 4.41e-04 | 16 | 282 | 3 | DOID:331 (implicated_via_orthology) | |
| Disease | Dermatitis, Allergic Contact | 4.58e-04 | 67 | 282 | 5 | C0162820 | |
| Disease | Prostate cancer, familial | 5.25e-04 | 69 | 282 | 5 | C2931456 | |
| Disease | Fetal Alcohol Syndrome | 5.32e-04 | 17 | 282 | 3 | C0015923 | |
| Disease | fetal alcohol spectrum disorder (biomarker_via_orthology) | 5.39e-04 | 4 | 282 | 2 | DOID:0050696 (biomarker_via_orthology) | |
| Disease | Inherited neuropathies | 5.69e-04 | 40 | 282 | 4 | C0598589 | |
| Disease | Tourette syndrome, schizophrenia | 6.34e-04 | 18 | 282 | 3 | EFO_0004895, MONDO_0005090 | |
| Disease | uterine fibroid | 6.93e-04 | 199 | 282 | 8 | EFO_0000731 | |
| Disease | FEV/FEC ratio | ARHGAP42 BNC2 ABCA3 RNLS NEB ASAP1 ME3 MET FCGR3A FCGR3B GNL2 HERC1 DTHD1 USP3 ARAP1 TCP11 AFF3 FAM83B TTC23 PANK4 UGGT2 TTC39A MYO15A RPL3 | 7.87e-04 | 1228 | 282 | 24 | EFO_0004713 |
| Disease | Adenocarcinoma | 8.91e-04 | 116 | 282 | 6 | C0001418 | |
| Disease | Carcinoma, Granular Cell | 8.91e-04 | 116 | 282 | 6 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 8.91e-04 | 116 | 282 | 6 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 8.91e-04 | 116 | 282 | 6 | C0205642 | |
| Disease | Carcinoma, Cribriform | 8.91e-04 | 116 | 282 | 6 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 8.91e-04 | 116 | 282 | 6 | C0205641 | |
| Disease | Partial Fetal Alcohol Syndrome | 8.93e-04 | 5 | 282 | 2 | C3661483 | |
| Disease | Alcohol Related Neurodevelopmental Disorder | 8.93e-04 | 5 | 282 | 2 | C0814154 | |
| Disease | inactive pancreatic lipase-related protein 1 measurement | 8.93e-04 | 5 | 282 | 2 | EFO_0801693 | |
| Disease | Gastric Adenocarcinoma | 8.94e-04 | 45 | 282 | 4 | C0278701 | |
| Disease | schizophrenia (is_implicated_in) | 9.20e-04 | 78 | 282 | 5 | DOID:5419 (is_implicated_in) | |
| Disease | Arthrogryposis | 1.01e-03 | 21 | 282 | 3 | C0003886 | |
| Disease | Chronic active hepatitis | 1.16e-03 | 22 | 282 | 3 | C0520463 | |
| Disease | Chronic Persistent Hepatitis | 1.16e-03 | 22 | 282 | 3 | C0149519 | |
| Disease | Hepatitis, Chronic | 1.16e-03 | 22 | 282 | 3 | C0019189 | |
| Disease | Cryptogenic Chronic Hepatitis | 1.16e-03 | 22 | 282 | 3 | C0524611 | |
| Disease | Squamous cell carcinoma | 1.26e-03 | 124 | 282 | 6 | C0007137 | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 1.32e-03 | 220 | 282 | 8 | EFO_0004529, EFO_0008317 | |
| Disease | Huntington's disease (is_implicated_in) | 1.33e-03 | 23 | 282 | 3 | DOID:12858 (is_implicated_in) | |
| Disease | amphetamine abuse (implicated_via_orthology) | 1.33e-03 | 6 | 282 | 2 | DOID:670 (implicated_via_orthology) | |
| Disease | Cystic kidney | 1.33e-03 | 6 | 282 | 2 | C0022679 | |
| Disease | Ehlers-Danlos syndrome (implicated_via_orthology) | 1.33e-03 | 6 | 282 | 2 | DOID:13359 (implicated_via_orthology) | |
| Disease | Leopard Syndrome 1 | 1.33e-03 | 6 | 282 | 2 | C4551484 | |
| Disease | Alcohol Related Birth Defect | 1.33e-03 | 6 | 282 | 2 | C3146244 | |
| Disease | blood urea nitrogen measurement | GGNBP2 USP38 ASCC3 GXYLT1 CHD9 ACAD10 SIM1 FAM83B NMD3 OVOL1 TTC21B UGGT2 | 1.47e-03 | 452 | 282 | 12 | EFO_0004741 |
| Disease | Squamous cell carcinoma of the head and neck | 1.54e-03 | 52 | 282 | 4 | C1168401 | |
| Disease | Mammary Carcinoma, Human | CD109 ETS2 PTEN STAT5A SYNE1 CAT SIM1 PRC1 MTHFR ITSN2 ATM CLUL1 ENO1 | 1.76e-03 | 525 | 282 | 13 | C4704874 |
| Disease | Mammary Neoplasms, Human | CD109 ETS2 PTEN STAT5A SYNE1 CAT SIM1 PRC1 MTHFR ITSN2 ATM CLUL1 ENO1 | 1.76e-03 | 525 | 282 | 13 | C1257931 |
| Disease | Mammary Neoplasms | CD109 ETS2 PTEN STAT5A SYNE1 CAT SIM1 PRC1 MTHFR ITSN2 ATM CLUL1 ENO1 | 1.82e-03 | 527 | 282 | 13 | C1458155 |
| Disease | Gonadal dysgenesis XX type deafness | 1.85e-03 | 7 | 282 | 2 | C0685838 | |
| Disease | CHARGE syndrome (implicated_via_orthology) | 1.85e-03 | 7 | 282 | 2 | DOID:0050834 (implicated_via_orthology) | |
| Disease | Morphine Abuse | 1.85e-03 | 7 | 282 | 2 | C0600272 | |
| Disease | angle-closure glaucoma (is_implicated_in) | 1.85e-03 | 7 | 282 | 2 | DOID:13550 (is_implicated_in) | |
| Disease | low affinity immunoglobulin gamma Fc region receptor II-a/b measurement | 1.85e-03 | 7 | 282 | 2 | EFO_0008211 | |
| Disease | Solid Neoplasm | 1.85e-03 | 7 | 282 | 2 | C0280100 | |
| Disease | Morphine Dependence | 1.85e-03 | 7 | 282 | 2 | C0026552 | |
| Disease | albuminuria | 2.11e-03 | 94 | 282 | 5 | EFO_0004285 | |
| Disease | Sezary Syndrome | 2.13e-03 | 27 | 282 | 3 | C0036920 | |
| Disease | red blood cell density measurement | RALGAPA1 PTEN ME3 ADGRL4 NUP205 FCGR3B FMN1 USP3 EP400 DNAH10 KALRN AFF3 ACAD10 RGS3 MTHFR KCNK5 MYO15A FYN | 2.17e-03 | 880 | 282 | 18 | EFO_0007978 |
| Disease | Breast Carcinoma | CD109 ETS2 PTEN STAT5A SYNE1 CAT SIM1 PRC1 MTHFR ITSN2 ATM CLUL1 ENO1 | 2.18e-03 | 538 | 282 | 13 | C0678222 |
| Disease | Bipolar Disorder | RAPGEF5 RPS6KA2 IMPACT CNTN4 TRPC7 SYNE1 GRIA1 GRIA2 GRIN2A GRIN2B MTHFR FYN | 2.30e-03 | 477 | 282 | 12 | C0005586 |
| Disease | mean corpuscular hemoglobin concentration | IQGAP2 MYO9B RPS6KA1 CLPX NEB PTEN ME3 ADGRL4 SLC26A8 FCGR3B HFM1 DYRK3 EP400 KALRN PIK3R3 ACAD10 MTHFR KCNK5 MYO15A DDX39A FYN | 2.32e-03 | 1105 | 282 | 21 | EFO_0004528 |
| Disease | attention deficit hyperactivity disorder (implicated_via_orthology) | 2.37e-03 | 28 | 282 | 3 | DOID:1094 (implicated_via_orthology) | |
| Disease | stimulant use measurement | 2.37e-03 | 28 | 282 | 3 | EFO_0600076 | |
| Disease | amino acid measurement | RPS6KA2 STYK1 CNTNAP3 RYR3 FMN1 GNPDA2 C5 MAP3K7 FAT4 SYNE1 CHST11 GRIN2B LRRK1 RERGL TMPRSS2 | 2.40e-03 | 678 | 282 | 15 | EFO_0005134 |
| Disease | cognitive disorder (biomarker_via_orthology) | 2.45e-03 | 8 | 282 | 2 | DOID:1561 (biomarker_via_orthology) | |
| Disease | placental insufficiency (biomarker_via_orthology) | 2.45e-03 | 8 | 282 | 2 | DOID:3891 (biomarker_via_orthology) | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 2.45e-03 | 8 | 282 | 2 | DOID:0060308 (implicated_via_orthology) | |
| Disease | diastolic blood pressure, self reported educational attainment | 2.45e-03 | 8 | 282 | 2 | EFO_0004784, EFO_0006336 | |
| Disease | bipolar disorder (is_implicated_in) | 2.63e-03 | 29 | 282 | 3 | DOID:3312 (is_implicated_in) | |
| Disease | urate measurement, bone density | CDR2 ETS2 MGLL SLC26A8 STRN FNDC1 GPR149 FAM135A CNTN4 SYNE1 SGTA SIM1 UGGT2 SEL1L2 | 2.73e-03 | 619 | 282 | 14 | EFO_0003923, EFO_0004531 |
| Disease | carboxypeptidase B measurement | 3.13e-03 | 9 | 282 | 2 | EFO_0801453 | |
| Disease | overall survival | 3.13e-03 | 9 | 282 | 2 | EFO_0000638 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DYPLYHLIKAQSQKK | 561 | Q7Z4L5 | |
| GVIYNKGFLHKNFYI | 521 | Q9HBW9 | |
| KDQLASKYLYHGQTL | 441 | Q15582 | |
| DHAVKYSKALIDYFK | 1081 | P51826 | |
| SLILQFAKEHGYKVF | 141 | P16118 | |
| FKKKHYAPLQAYLRQ | 406 | Q96L91 | |
| TYFLTIHALQKKAYL | 236 | P41595 | |
| IGHTVAKQVYYKNKR | 2561 | Q96N23 | |
| AKNGTYFRIHINKYK | 1081 | Q8NHU2 | |
| KSLLIGVFKHGYEKY | 1631 | Q9HCK8 | |
| LYYNGVDVTELAKKH | 336 | Q9BZ76 | |
| YSLLKSEALKFHLYN | 216 | Q8IZ81 | |
| YFNLYREKFHEKIKG | 266 | Q8IZ81 | |
| QETIYSKKFGNIHYG | 561 | Q9H7T0 | |
| YCKFHYKTDQGIKNL | 231 | P04040 | |
| AKKVLSVAVYNHYKR | 186 | O76031 | |
| YDKGTLKIHYNAVHL | 451 | Q6ZN30 | |
| LTLHGLQQYYVKLKD | 256 | O00148 | |
| AKIFRGQVYSELKYH | 51 | Q9HC16 | |
| LYDKDHYKLALGQIN | 86 | Q9BZE4 | |
| NYIYVKFATIKSHAL | 3996 | Q6V0I7 | |
| KFATIKSHALLLYNY | 4001 | Q6V0I7 | |
| FYDKGTLKIHYNAVH | 366 | Q01954 | |
| ILEYKNAHGKIIILY | 211 | Q9BYV8 | |
| YSLYFLDHLVKALQK | 1456 | Q8IYW2 | |
| NLKGSVLYHLAVKAY | 866 | Q8IWV2 | |
| HLYFYAQLKGLSRQK | 626 | Q99758 | |
| KKYGAGLTNVEYAHL | 726 | Q6JQN1 | |
| ANYVHSKGLKLGIYA | 121 | P06280 | |
| YENNLKPVLKHVKAY | 1321 | O60706 | |
| LEKVYAKVHGSYEHL | 151 | Q9HC96 | |
| NIYGEKYKQHLKQFL | 386 | A6NGH8 | |
| VGHYDGNVAIYNLKK | 401 | Q9UI46 | |
| NTEKLNYGKEHQYKL | 221 | O94985 | |
| HYLEDILAKLGKHQY | 621 | Q7L2E3 | |
| FKENDYLQKALAYHL | 226 | Q8ND07 | |
| YLQKALAYHLKETDA | 231 | Q8ND07 | |
| FRNYKYDALKIIHQA | 56 | Q3KRA6 | |
| KYKEVVTQHFLGVTY | 66 | Q8IVL8 | |
| LKYVLLAYDVKQIFH | 136 | Q8N608 | |
| STCKFYKGLYLNQHK | 746 | Q8TE60 | |
| KNHIRKDGDYYLNIK | 1721 | P59510 | |
| YAKKRNVLIGHSYGV | 241 | Q96I13 | |
| FYIQAYKALKHKTAN | 731 | Q04656 | |
| IYNIGKSHQGLKLYA | 341 | Q8N436 | |
| LKFLVDGKYIYAHKV | 396 | O95199 | |
| VASAIYAKYKLHGFQ | 296 | Q8IUH3 | |
| IKLYTKHGTLKYQTD | 56 | P69849 | |
| FIQGYHVYLKSKARQ | 656 | Q99650 | |
| KLLVHKYGLAVFQAF | 1076 | P49796 | |
| KDSAVLDQSAKYYHL | 586 | Q9BXF6 | |
| YLFQKYVKESHGKDI | 186 | Q8IXN7 | |
| KYTEAEYQAAILHLK | 716 | Q68DA7 | |
| YYKKILSLHAAVKSG | 506 | Q86VS3 | |
| LYKTKSNKELHGFLF | 1441 | Q9NZM3 | |
| RKYDFHLKYLLKTQE | 411 | O75747 | |
| IIYQGQYKKAIASLH | 456 | Q9NVR2 | |
| KKADNVVNIARYLYH | 891 | Q92621 | |
| FNHDVLGKNLKYRIY | 21 | Q9HCL0 | |
| HAFKVNVYFGAHLLK | 321 | Q9ULD8 | |
| LGNNKVEVYLHKIYS | 836 | Q6NSI4 | |
| KGYQSVTLLLLHYKA | 506 | Q96NW4 | |
| GQYKKSYEKIHLDFL | 956 | P16234 | |
| VKGKTHTYYQVLIDA | 126 | Q9Y2S7 | |
| SCYKGHKEIAQYLLE | 156 | Q96JP0 | |
| ITSLYHKIQLNGYKF | 671 | Q9BQK8 | |
| HKIQLNGYKFLYCSA | 676 | Q9BQK8 | |
| KYELRVNYHLVNVKG | 531 | P42898 | |
| IKLYTKHGTLKYQTD | 56 | Q5JPE7 | |
| KHFVNLYRYFGDKIQ | 156 | Q6PK18 | |
| PKKVGVRYYETHNVK | 691 | Q13823 | |
| GTSVAAIKLYILHKY | 71 | Q8IZA3 | |
| SYQGKFHEAAKLYKR | 701 | Q9HBG6 | |
| DTKNHAYIIINKLGY | 1081 | Q9UJ55 | |
| LHYVVYSGLENIKKL | 106 | Q9HBL8 | |
| SQDKTLKIYEGAYHV | 256 | Q99685 | |
| DAKKLYTLFYVHGSK | 131 | Q9H3C7 | |
| IAYQIASGLAYLHKK | 1366 | Q38SD2 | |
| IKHYAGKVTYQVHKF | 1701 | Q9UKN7 | |
| VKLHYAFQTEGKLYL | 131 | P51812 | |
| QRVFYALSNKYHDKG | 111 | Q15751 | |
| KSLGQRVLDELKHYY | 151 | O95202 | |
| ENKKYLYLVLEHVSG | 86 | Q8IWQ3 | |
| YKTYVGGILLLSKQH | 196 | Q9UBV7 | |
| NDKHLKNIYKEAYRI | 491 | Q5BJE1 | |
| KNIYKEAYRIGTLFH | 496 | Q5BJE1 | |
| YFKNRGIYTLNEHDK | 336 | Q5T0W9 | |
| KEDLQIYFKYHKNLP | 706 | Q86YR7 | |
| AFKSGIVQYLQKHSY | 456 | Q9NZ08 | |
| AANLHSKIYYNGDKV | 346 | P05160 | |
| SNKAGLHYFKNVVLV | 1406 | Q9P2D6 | |
| IGKHVKGYHYIIANL | 226 | P42262 | |
| HVKGYHYIIANLGFK | 231 | P48058 | |
| YVKSYGKNIDSKLHV | 741 | O15031 | |
| FDYQALNKYHLKVIA | 2131 | Q9NYQ8 | |
| KNYYTQKLHLLKEFP | 36 | O95279 | |
| HLIHGKVKEFYSYQN | 126 | P55157 | |
| NFYKIIDYILHGKEE | 316 | P51160 | |
| DKNIIHKTSGKRYVY | 426 | P15036 | |
| HTYCGKIYKIFIKQL | 411 | Q4G148 | |
| GHTKYVYKNKLLTSE | 1516 | O60229 | |
| HKKLLDENKSLSTYY | 571 | O43318 | |
| IKLYTKHGTLKYQTD | 56 | Q15155 | |
| AKLYHKVSQNGYKFL | 706 | Q14693 | |
| IVYGNYESKKHKQGF | 561 | O00522 | |
| VKLHYAFQTEGKLYL | 136 | Q9UK32 | |
| ILIHLAKFYGYDNVK | 426 | Q96GN5 | |
| KRKGHEYTNIKYSLA | 536 | Q06124 | |
| LALYKKHAETFYLSK | 271 | Q8NDA8 | |
| ATKLKEQLHGYFEYI | 371 | Q9NY59 | |
| KQKHLKYYLVRSSQG | 211 | Q9C091 | |
| LYENKKIASATHNIY | 206 | Q9P2X3 | |
| KNVKYIIDKYGNHPA | 236 | Q5SRI9 | |
| SHLKKIHGVQQKYAY | 191 | O14753 | |
| KEKYIHQNYTKALAG | 531 | Q02809 | |
| TKLAYYSTVQHKVAK | 46 | Q9NVE7 | |
| LSFQKSYGIYKIAHE | 401 | Q86SP6 | |
| HIAGKLTYASQKYKN | 116 | A2PYH4 | |
| KLIKIYHRDGKYGFS | 111 | Q92569 | |
| KYNQELYTTHGLIKG | 366 | Q8IYK2 | |
| AVLLYKISNLLKFYH | 371 | Q9Y2V7 | |
| AEVYHNLKNVIKEKY | 186 | P06733 | |
| HFTALLYAEIYADKK | 1951 | Q13315 | |
| KSLLIGVFKHGYEKY | 1681 | Q3L8U1 | |
| TVKKVEYDHGKLNLY | 1336 | Q6YHK3 | |
| LKIYHLRQEDSGKYN | 361 | O75054 | |
| SFNRHNLKYYVLPKK | 856 | P54132 | |
| QFSHAKYNKILNKYG | 1046 | Q92608 | |
| YIHLKKAIVSNRGQY | 61 | Q8IZD9 | |
| NAYYAKIKAHKNSLG | 126 | Q5T0U0 | |
| LRKSHLAKEGLYQYK | 61 | Q14152 | |
| KEKNHQLYKPYTNGI | 66 | Q86UL3 | |
| KHGLEFYGYIKLINF | 81 | O60678 | |
| AKELYRDYNHGVLKI | 41 | Q9H2C2 | |
| TYQFFVKHGELKVYK | 846 | Q03188 | |
| LHEVDTQYSALKVKY | 346 | Q01850 | |
| SIYAYLNSHLDLIKK | 361 | Q96C11 | |
| IINHSVDKKGNYHYL | 636 | Q12873 | |
| EHYNIAYGKSLKSLK | 71 | Q4ZHG4 | |
| QKTVDKYHALYISAL | 301 | Q6ZPD8 | |
| FAKVLHGEQYLELYK | 401 | P51659 | |
| KHYKIRKLDNGGYYI | 201 | P06241 | |
| ITHYNYLILSKGKII | 496 | P01031 | |
| RLYKYDHNFVKAINA | 166 | P53634 | |
| GHYLYNEKETKSLHV | 291 | Q8N5I4 | |
| QATYHGNKEIVKYLL | 366 | Q68DC2 | |
| KKGVDLLQNLIKYYH | 231 | Q9ULH1 | |
| GKDYGKDYTLIFHLQ | 576 | Q6ZMT9 | |
| ENKKYLYLVLEHVSG | 101 | Q8TDC3 | |
| LHKVTYLQNGKDRKY | 136 | O75015 | |
| KLIEYHKNGHLSFKY | 51 | Q8TDQ7 | |
| LRIAIKVLDYAYKHN | 546 | Q16798 | |
| LKGIVTKLYSRQGYH | 66 | Q92913 | |
| LSVYQIKVHRKYTGE | 2956 | Q14204 | |
| SLTHLVKLGKAYKYI | 51 | P51808 | |
| VSYGKVKLVLKHNRY | 161 | P19447 | |
| EKYKNSKYHGVSLLN | 411 | P20248 | |
| IIKLEKNGIGYHYIL | 216 | P42261 | |
| NEYVSFKQYVGKHIL | 51 | O75715 | |
| LHKVTYLQNGKGRKY | 136 | P08637 | |
| EKAYAKLHGSYEALK | 206 | P20807 | |
| LSKQYHYDFGLRALK | 1996 | Q8IVF4 | |
| YTKKKAIQLYRHGTS | 246 | Q7Z3Z3 | |
| HYQYVGKLAGRLKEA | 21 | Q99500 | |
| DFSKYNKTIYDVLLH | 1586 | Q6ZTR5 | |
| AAKKGHYEVVQYLLS | 846 | Q9H9B1 | |
| ALKQYKHHLTAYEKL | 146 | O43781 | |
| FYYTKLLQGVAELKH | 706 | Q6PJW8 | |
| LYYNGVDVTELAKKH | 336 | Q96NU0 | |
| SKDKNILPKVFHYYG | 286 | Q96DY7 | |
| IHENVKVLKEQYLGY | 406 | Q9BVL2 | |
| FLDSKHKNHYKIYNL | 56 | P60484 | |
| LSHYIKTAKKLYELN | 121 | Q86X27 | |
| SAYYNNPEHVKLLIK | 156 | Q9Y283 | |
| KKKVHYYNEISVSIA | 206 | Q6PHW0 | |
| NLGLLHKYYVKNALV | 116 | Q8IWE5 | |
| GFYTKQILEGLKYLH | 781 | Q99683 | |
| HKYLKHRNIVQYLGS | 701 | Q6ZN16 | |
| KFYTKQILEGLKYLH | 751 | Q6ZN16 | |
| DKEYYSVHNKTGAKL | 1231 | P08581 | |
| KYKTQIDHYVGIARD | 996 | O95197 | |
| KYHKLKYGTELNQGD | 131 | Q13033 | |
| QERAKYHKLKYGTEL | 111 | O43815 | |
| EKALNSIIDVYHKYS | 6 | P05109 | |
| SIIDVYHKYSLIKGN | 11 | P05109 | |
| QLHEYVKQGNYVKVK | 26 | Q8IWB6 | |
| GEYASNFESIYKKHL | 31 | Q9H628 | |
| ITLYKLYKKGSHIFE | 86 | Q7Z6W1 | |
| SLNKHVEAVAYYKKA | 171 | O43765 | |
| VRQNKNHYLLEYKKG | 666 | Q9P0V3 | |
| NHYLLEYKKGDGIAL | 671 | Q9P0V3 | |
| NIKNSIGYKAIHEYL | 6936 | Q8NF91 | |
| IGYKAIHEYLQKYKG | 6941 | Q8NF91 | |
| VKHAYNLYKESQTVG | 141 | A0A494BZU4 | |
| EKKHQDFLGYLYRKF | 1356 | A0AVI2 | |
| QKGYHHRTEINKKIY | 271 | P39023 | |
| YYSILEKHLNLSAKK | 141 | A6NI28 | |
| LHLIGRKGLDQDYYK | 306 | Q5TEA6 | |
| HTPVNAKVVKDYYKI | 1406 | P21675 | |
| SITFVNVYYLKHKLL | 561 | Q96RN1 | |
| YGLRYIAKVLKNSIH | 1071 | Q13576 | |
| SYVKYQVIGKNHVAV | 211 | Q14249 | |
| KNGDLHLKQIAYYKR | 6 | Q9NXP7 | |
| LKNYYEVHKELFEGV | 341 | O43663 | |
| ALLRHYSAKKYQGKE | 121 | Q92565 | |
| HHLLLVKGQVTTKYY | 281 | Q14190 | |
| HHLLLVKGQVTTKYY | 281 | P81133 | |
| LCDYGTHNILDLKKY | 581 | Q562F6 | |
| ILLATDSYKVTHYKQ | 11 | P43490 | |
| YQLHEVTAYLLEKKG | 1066 | Q8N3P4 | |
| ELVHGYILVYSAKRK | 846 | Q13017 | |
| QRYYLKHHGKLKDNS | 696 | Q01826 | |
| KLFEQSKLKRYHAYN | 326 | Q5VX52 | |
| GLKLLTKNGHVYKYD | 61 | Q08945 | |
| KLGHYATQLQKTYDR | 86 | P42229 | |
| VGDKVQLYKNLEEYH | 461 | Q96P48 | |
| HIYHSEYFLALKKQV | 1231 | Q8N3C0 | |
| TQKYNISFHKRYGTK | 201 | Q9NPF2 | |
| NGFVLYVLIKTYHKK | 41 | Q9Y271 | |
| YVLIKTYHKKSAFQV | 46 | Q9Y271 | |
| NFIGYVVAKALQHFK | 446 | Q15846 | |
| YSLESGHDQKKKYVF | 456 | Q969H4 | |
| LQHEKEGYTIYKTQL | 1166 | O75153 | |
| LIYHQAIHGIGKLYK | 566 | Q96IR2 | |
| YDLTEKQVYHIGKQV | 221 | Q6J9G0 | |
| IGLTVHYVRYNQKKT | 36 | Q9UL52 | |
| LSKYYLKVHNRKHTG | 301 | P10074 | |
| NKGLAHYLKEYKEAI | 131 | Q96EI5 | |
| HGALKVLYLSKYVLN | 151 | Q8WWU5 | |
| FEYNKSKYHLKDVIV | 176 | Q4G0F5 | |
| SKYHLKDVIVGKIYF | 181 | Q4G0F5 | |
| LLYLKQEKTHSGVEY | 141 | Q6P2D0 | |
| EKGGVYLHTSAKKYQ | 11 | Q9HA65 | |
| TIALNLKKSDRYYHG | 371 | P32780 | |
| SFQEAILKKYGKYGH | 126 | Q8IYN0 | |
| ILKKYGKYGHDNLQL | 131 | Q8IYN0 | |
| SEGYLLFYHKQGLEK | 696 | Q70EK9 | |
| KTVYHYLISQDKAGK | 206 | P43403 | |
| EAKNYYKQGIGHLLR | 41 | Q8N0X7 | |
| FQKVILREYGNYGHK | 126 | Q8NE65 | |
| QKVILRTYGKYGHEN | 96 | Q03936 | |
| AGNVDIYKKLYHSDA | 216 | O15393 | |
| GKAYNRVYLLNEHVK | 511 | Q96MU6 | |
| EYGKSLNSKYLFVEH | 251 | Q6P9A3 | |
| CGKIFYNKSYLTKHN | 586 | Q06732 | |
| KAFSLYGYLKQHQKI | 421 | Q86YE8 | |
| LHIYKRKNVLKEAYS | 71 | Q96MH6 | |
| YKQGKLHAYKLICNT | 1141 | Q6GYQ0 | |
| TVFDKLNHEYKKYLD | 411 | Q96DM3 | |
| KKHQRFYDELLAYGV | 71 | Q5VYX0 | |
| FFKGLEIYQTKLLHY | 4391 | Q15413 | |
| QYLHYALFKANRLEK | 146 | Q92791 | |
| LSKNYSYVIHAKIKA | 191 | Q6FHJ7 | |
| SAGKQYLEHASKYLA | 106 | Q86SZ2 | |
| AFGKYQHKNLLILYD | 526 | O14787 | |
| QKVILRSYGKYGHDN | 96 | P0DPD5 | |
| KDALFKHYGKIHQYT | 1916 | O60281 | |
| GTAILKDYYLKHKFL | 781 | Q9UKY1 | |
| AYFHQAAKLKGIGEY | 1076 | Q92620 | |
| VKGLVKQHIDSFNYF | 36 | Q9NW08 | |
| VAYIGYLHAIQENKK | 61 | Q96KF7 | |
| LELNFKGAEEIYYKH | 161 | Q96RJ0 | |
| LKSHVYKKTLQALIY | 456 | O14795 | |
| QRSDDIHLQKGKEYY | 446 | Q86WI1 | |
| AKNKSFYPYIHVVNK | 1626 | Q9UGU0 | |
| LGEYKGHKNQEYKLD | 226 | Q9BRX9 | |
| YHFCKAKIKGYQRLI | 871 | Q9NYK1 | |
| AYVLLYKKQHSTNGL | 941 | Q8NB14 | |
| KFLALGTHYGKVYLL | 56 | P49754 | |
| HYTLKDNKVYIKTHG | 191 | Q6UW63 | |
| KHKYQINIDGTVAAY | 361 | Q6UW63 | |
| LQKANVRLYHVYEKG | 246 | O15195 | |
| HKFGKKVIYFNYLSE | 161 | P85298 | |
| GYFHLANIFYDLKKL | 216 | Q9H0C1 | |
| GKIFYNKSYLTKHNR | 586 | Q06730 | |
| AKAYILFYVEHQAKA | 501 | Q9Y6I4 | |
| KKVHSVSALAKGYYD | 406 | Q8IX04 | |
| KSKEALSHYQAALEY | 201 | Q5W5X9 | |
| KGIYFAKDAIYSHKN | 816 | Q7Z2W4 | |
| LGVLNGKKYHADLYV | 241 | Q9NRZ5 | |
| YHKINKDLFVLTYGA | 11 | Q5T215 | |
| KYHISALYVVDLKKF | 1386 | Q9NYU1 | |
| FYLETLNTKQKLYHK | 1001 | Q96QU8 | |
| AYVKKIQFKLHESYG | 61 | O95619 | |
| ISANEKKIKYDHYLI | 531 | Q5SRH9 | |
| HKLNLDRYLNYFATK | 871 | O95185 | |
| KYHISALYVVDLKKF | 1411 | Q9NYU2 | |
| KEDVSLHGYKKYLLS | 126 | Q12792 | |
| VVLKYDHKFIENIGY | 636 | Q9HCX4 | |
| KAKNYEEALRLYQHA | 21 | Q9UN37 | |
| YAYLKINLTKALGHH | 11 | Q8WZ26 | |
| YAISIKYNNEAKHIK | 706 | Q9UKW4 | |
| AVKEFGYHRYKFIIK | 136 | Q8IZS6 | |
| GYLEYLIKHNYGKDK | 366 | Q16719 | |
| KLHYAFQTEGKLYLI | 126 | Q15418 | |
| IVKLHYAFQTEGKLY | 121 | Q15349 | |
| IAKLYHSINENGYKF | 716 | Q92539 | |
| VTGAVKNTKYHQLYD | 866 | Q8IZF0 | |
| KNTKYHQLYDLLGLV | 871 | Q8IZF0 | |
| YIYAGLHHQKKLSDF | 536 | Q8WXR4 | |
| YVALSQKHKYKVLFR | 526 | Q86UW6 | |
| LKHRFLQQKIYTYAG | 166 | Q13459 | |
| QKTLHKKTFYYLEQL | 161 | Q96D46 | |
| VKFTYDLYLVTNGKH | 471 | Q12879 | |
| YDLYLVTNGKHGKKI | 476 | Q13224 | |
| AYKAKGEEIIHKYNL | 1016 | P20929 |